10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended March 30, 2019

OR

[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from ________ to ________.

Commission file number 1-34192

MAXIM INTEGRATED PRODUCTS, INC.

(Exact name of registrant as specified in its charter)

Delaware  (State or Other Jurisdiction of Incorporation or Organization) 94-2896096 (I.R.S. Employer I. D. No.)

160 Rio Robles

San Jose, California 95134

(Address of Principal Executive Offices including Zip Code)

(408) 601-1000

(Registrant’s Telephone Number, Including Area Code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file reports), and (2) has been subject to such filing requirements for the past 90 days. YES [x] NO [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES [x] NO [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller” reporting company in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer [x] Accelerated filer [ ] Non-accelerated filer [ ]
(Do not check if a smaller reporting company) Smaller reporting company [ ] Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revisited financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). (Check one): YES [ ] NO [x]

As of April 18, 2019 there were 272,425,069 shares of Common Stock, par value $.001 per share, of the registrant outstanding.

MAXIM INTEGRATED PRODUCTS, INC.

INDEX

PART I - FINANCIAL INFORMATION	Page
Item 1. Financial Statements (Unaudited)	3
Condensed Consolidated Balance Sheets as of March 30, 2019 and June 30, 2018	3
Condensed Consolidated Statements of Income for the Three and Nine Months Ended March 30, 2019 and March 31, 2018	4
Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended March 30, 2019 and March 31, 2018	5
Condensed Consolidated Statements of Shareholders' Equity for the Three and Nine Months Ended March 30, 2019 and March 31, 2018	6
Condensed Consolidated Statements of Cash Flows for the Nine Months Ended March 30, 2019 and March 31, 2018	8
Notes to Condensed Consolidated Financial Statements	9
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	27
Item 3. Quantitative and Qualitative Disclosures About Market Risk	32
Item 4. Controls and Procedures	32
PART II - OTHER INFORMATION	33
Item 1. Legal Proceedings	33
Item 1A. Risk Factors	33
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	33
Item 3. Defaults Upon Senior Securities	33
Item 4. Mine Safety Disclosures	33
Item 5. Other Information	33
Item 6. Exhibits	34
SIGNATURE	35

2

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

	March 30, 2019			June 30, 2018
	(in thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	1,654,563		$	1,543,484
Short-term investments	243,864			1,082,915
Total cash, cash equivalents and short-term investments	1,898,427			2,626,399
Accounts receivable, net of allowances of $608 at March 30, 2019 and $140,296 at June 30, 2018	381,152			280,072
Inventories	272,832			282,390
Other current assets	24,358			21,548
Total current assets	2,576,769			3,210,409
Property, plant and equipment, net	571,955			579,364
Intangible assets, net	61,036			78,246
Goodwill	532,251			532,251
Other assets	61,843			51,291
TOTAL ASSETS	$	3,803,854		$	4,451,561
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	86,798		$	92,572
Price adjustment and other revenue reserves	106,011			—
Income taxes payable	44,179			17,961
Accrued salary and related expenses	128,365			151,682
Accrued expenses	33,644			35,774
Current portion of debt	—			499,406
Total current liabilities	398,997			797,395
Long-term debt	992,225			991,147
Income taxes payable	688,780			661,336
Other liabilities	61,105			70,743
Total liabilities	2,141,107			2,520,621
Commitments and contingencies (Note 11)
Stockholders’ equity:
Common stock and capital in excess of par value	279			279
Retained earnings	1,672,938			1,945,646
Accumulated other comprehensive loss	(10,470		)	(14,985		)
Total stockholders’ equity	1,662,747			1,930,940
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY	$	3,803,854		$	4,451,561

See accompanying Notes to Condensed Consolidated Financial Statements.

3

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

	Three Months Ended					Nine Months Ended
	March 30, 2019		March 31, 2018			March 30, 2019		March 31, 2018
	(in thousands, except per share data)
Net revenues	$	542,383	$	648,599		$	1,757,784	$	1,846,913
Cost of goods sold	201,552		224,653			613,669		639,460
Gross margin	340,831		423,946			1,144,115		1,207,453
Operating expenses:
Research and development	107,075		114,390			330,086		338,886
Selling, general and administrative	74,116		81,304			233,487		240,308
Intangible asset amortization	756		876			2,285		3,623
Impairment of long-lived assets	—		—			753		892
Severance and restructuring expenses	1,744		2,272			3,917		14,227
Other operating expenses (income), net	—		266			60		(1,535		)
Total operating expenses	183,691		199,108			570,588		596,401
Operating income	157,140		224,838			573,527		611,052
Interest and other income (expense), net	3,318		(2,534		)	3,244		(9,868		)
Income before provision for income taxes	160,458		222,304			576,771		601,184
Income tax provision (benefit)	29,845		28,677			116,843		328,038
Net income	$	130,613	$	193,627		$	459,928	$	273,146
Earnings per share:
Basic	$	0.48	$	0.69		$	1.67	$	0.97
Diluted	$	0.47	$	0.68		$	1.64	$	0.95
Shares used in the calculation of earnings per share:
Basic	273,221		280,850			275,831		281,525
Diluted	276,610		285,881			279,680		286,221

See accompanying Notes to Condensed Consolidated Financial Statements.

4

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

	Three Months Ended						Nine Months Ended
	March 30, 2019			March 31, 2018			March 30, 2019		March 31, 2018
	(in thousands)
Net income	$	130,613		$	193,627		$	459,928	$	273,146
Other comprehensive income (loss), net of tax:
Change in net unrealized gains and losses on available-for-sale securities, net of tax benefit (expense) of $97, $274, ($131), and $274, respectively	1,139			(1,213		)	3,116		(3,433		)
Change in net unrealized gains and losses on cash flow hedges, net of tax benefit (expense) of $69, $6, $(241), and $(45), respectively	(351		)	(217		)	1,167		133
Change in net unrealized gains and losses on post-retirement benefits, net of tax benefit (expense) of $(23), $(4), $(60), and $(168), respectively	78			18			232		(14		)
Other comprehensive income (loss), net	866			(1,412		)	4,515		(3,314		)
Total comprehensive income	$	131,479		$	192,215		$	464,443	$	269,832

See accompanying Notes to Condensed Consolidated Financial Statements.

5

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(Unaudited)

	Three Months Ended March 30, 2019
	Common Stock				Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Total Stockholders' Equity
	Shares		Par Value
	(in thousands)
Balance, December 29, 2018	274,326		$	279	$	—		$	1,766,471		$	(11,336	)	$	1,755,414
Net income	—		—		—			130,613			—			130,613
Other comprehensive income, net	—		—		—			—			866			866
Repurchase of common stock	(2,210	)	—		(18,411		)	(98,580		)	—			(116,991		)
Net issuance of restricted stock units	402		—		(9,582		)	—			—			(9,582		)
Stock options exercised	177		—		5,143			—			—			5,143
Stock-based compensation	—		—		22,850			—			—			22,850
Common stock issued under Employee Stock Purchase Plan	—		—		—			—			—			—
Dividends paid, $0.46 per common share	—		—		—			(125,566		)	—			(125,566		)
Balance, March 30, 2019	272,695		$	279	$	—		$	1,672,938		$	(10,470	)	$	1,662,747
	Nine Months Ended March 30, 2019
	Common Stock				Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Total Stockholders' Equity
	Shares		Par Value
	(in thousands)
Balance, June 30, 2018	278,664		$	279	$	—		$	1,945,646		$	(14,985	)	$	1,930,940
Net income	—		—		—			459,928			—			459,928
Other comprehensive income, net	—		—		—			—			4,515			4,515
Repurchase of common stock	(8,032	)	—		(82,155		)	(354,892		)	—			(437,047		)
Cumulative effect adjustment for adoption of ASU 2016-01	—		—		—			2,487			—			2,487
Net issuance of restricted stock units	980		—		(23,026		)	—			—			(23,026		)
Stock options exercised	699		—		18,986			—			—			18,986
Stock-based compensation	—		—		65,035			—			—			65,035
Modification of liability to equity instruments (1)	—		—		3,471			—			—			3,471
Common stock issued under Employee Stock Purchase Plan	384		—		17,689			—			—			17,689
Dividends paid, $1.38 per common share	—		—		—			(380,231		)	—			(380,231		)
Balance, March 30, 2019	272,695		$	279	$	—		$	1,672,938		$	(10,470	)	$	1,662,747

_____________________________

(1) In December 2018, $3.5 million was reclassified from accrued salaries to additional paid-in capital due to a settlement agreement relating to the expiration of stock options.

See accompanying Notes to Condensed Consolidated Financial Statements.

6

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(Unaudited)

	Three Months Ended March 31, 2018
	Common Stock					Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Total Stockholders' Equity
	Shares		Par Value
	(in thousands)
Balance, December 30, 2017	281,438		$	283		$	—		$	1,997,207		$	(11,792	)	$	1,985,698
Net income	—		—			—			193,627			—			193,627
Other comprehensive income, net	—		—			—			—			(1,412		)	(1,412		)
Repurchase of common stock	(2,140	)	(2		)	(18,659		)	(109,039		)	—			(127,700		)
Net issuance of restricted stock units	387		1			(9,642		)	—			—			(9,641		)
Stock options exercised	294		1			7,714			—			—			7,715
Stock-based compensation	—		—			20,587			—			—			20,587
Common stock issued under Employee Stock Purchase Plan	—		—			—			—			—			—
Dividends paid, $0.42 per common share	—		—			—			(117,883		)	—			(117,883		)
Balance, March 31, 2018	279,979		$	283		$	—		$	1,963,912		$	(13,204	)	$	1,950,991
	Nine Months Ended March 31, 2018
	Common Stock					Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Total Stockholders' Equity
	Shares		Par Value
	(in thousands)
Balance, June 24, 2017	282,912		$	283		$	—		$	2,212,301		$	(9,890	)	$	2,202,694
Net income	—		—			—			273,146			—			273,146
Other comprehensive (loss), net	—		—			—			—			(3,314		)	(3,314		)
Repurchase of common stock	(5,286	)	(3		)	(79,174		)	(200,769		)	—			(279,946		)
Net issuance of restricted stock units	906		1			(21,162		)	—			—			(21,161		)
Stock options exercised	1,031		2			26,382			—			—			26,384
Stock-based compensation	—		—			58,979			—			—			58,979
Common stock issued under Employee Stock Purchase Plan	416		—			14,975			—			—			14,975
Dividends paid, $1.14 per common share	—		—			—			(320,766		)	—			(320,766		)
Balance, March 31, 2018	279,979		$	283		$	—		$	1,963,912		$	(13,204	)	$	1,950,991

See accompanying Notes to Consolidated Financial Statements.

7

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Nine Months Ended
	March 30, 2019			March 31, 2018
	(in thousands)
Cash flows from operating activities:
Net income	$	459,928		$	273,146
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	64,973			58,932
Depreciation and amortization	85,176			109,768
Deferred taxes	(12,161		)	6,257
Loss (gain) on disposal of property, plant and equipment	3,324			572
Impairment of investments in privately-held companies	265			850
Other adjustments	—			42
Changes in assets and liabilities:
Accounts receivable	5,475			(60,194		)
Inventories	9,620			(23,326		)
Other current assets	(3,026		)	31,703
Accounts payable	(10,971		)	3,429
Income taxes payable	53,662			280,664
Deferred margin on shipments to distributors	—			(14,974		)
Accrued salary and related expenses	(19,845		)	1,826
All other accrued liabilities	1,953			4,110
Net cash provided by (used in) operating activities	638,373			672,805
Cash flows from investing activities:
Purchases of property, plant and equipment	(52,170		)	(53,664		)
Proceeds from sale of property, plant and equipment	34			5,761
Proceeds from sale of available-for-sale securities	30,192			100,004
Proceeds from maturity of available-for-sale securities	1,027,083			422,500
Payment in connection with business acquisition, net of cash acquired	(2,949		)	(57,773		)
Purchases of available-for-sale securities	(214,587		)	(1,122,291		)
Purchases of privately-held companies' securities	(1,676		)	(3,356		)
Other investing activities	(540		)	—
Net cash provided by (used in) investing activities	785,387			(708,819		)
Cash flows from financing activities:
Repayment of debt	(500,000		)	—
Contingent consideration paid	(9,052		)	—
Net issuance of restricted stock units	(23,026		)	(21,162		)
Proceeds from stock options exercised	18,986			26,383
Issuance of common stock under employee stock purchase program	17,689			14,975
Repurchase of common stock	(437,047		)	(279,944		)
Dividends paid	(380,231		)	(320,766		)
Net cash provided by (used in) financing activities	(1,312,681		)	(580,514		)
Net increase (decrease) in cash and cash equivalents	111,079			(616,528		)
Cash and cash equivalents:
Beginning of period	$	1,543,484		$	2,246,121
End of period	$	1,654,563		$	1,629,593
Supplemental disclosures of cash flow information:
Cash paid, net, during the period for income taxes	$	74,385		$	17,281
Cash paid for interest	$	31,751		$	31,750
Noncash financing and investing activities:
Accounts payable related to property, plant and equipment purchases	$	15,252		$	6,798

See accompanying Notes to Condensed Consolidated Financial Statements.

8

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1: BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements of Maxim Integrated Products, Inc. and all of its majority-owned subsidiaries (collectively, the “Company” or “Maxim Integrated”) included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with generally accepted accounting principles of the United States of America (“GAAP”) have been condensed or omitted pursuant to applicable rules and regulations. In the opinion of management, all adjustments of a normal recurring nature which were considered necessary for fair statement have been included. The year-end condensed consolidated balance sheet data were derived from audited consolidated financial statements but do not include all disclosures required by GAAP. The results of operations for the nine months ended March 30, 2019 are not necessarily indicative of the results to be expected for the entire year. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2018.

The Company has a 52-to-53-week fiscal year that ends on the last Saturday in June. Accordingly, every fifth or sixth fiscal year will be a 53-week fiscal year. Fiscal year 2018 was a 53-week fiscal year and fiscal year 2019 is a 52-week fiscal year. The second quarter of fiscal year 2018 was a 14-week quarter and the second quarter of fiscal year 2019 was a 13-week quarter.

NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Recently Issued Accounting Pronouncements

(i) New Accounting Updates Recently Adopted

In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09, Revenue from Contracts with Customers (Topic 606). This standard provides a single set of guidelines for revenue recognition to be used across all industries. Under the new standard, revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires reporting companies to disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers.

On July 1, 2018, the Company adopted Topic 606 and related amendments (ASU 2015-14, Deferral of the Effective Date; ASU 2016-08, Principal versus Agent Considerations; ASU 2016-10, Identifying Performance Obligations and Licensing, ASU 2016-12, Narrow-Scope Improvements and Practical Expedients and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers) using the modified retrospective method applied to all contracts that are not completed at the date of initial application (i.e., July 1, 2018). Results for reporting periods beginning after July 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with historic accounting standards under Topic 605.

There was no impact on the opening retained earnings as of July 1, 2018 due to the adoption of Topic 606. However, in conjunction with the adoption of the new standard, the Company recorded a reclassification of accrued revenue reserves for price adjustments and other revenue reserves from accounts receivable, net to price adjustment and other revenue reserves within current liabilities.

The cumulative effect of the changes to the condensed consolidated balance sheet from the adoption of Topic 606 was as follows (in thousands):

	As of June 30, 2018		Effect of Adoption of Topic 606		As of July 1, 2018
Accounts receivable, net	$	280,072	$	141,652	$	421,724
Price adjustment and other revenue reserves	—		141,652		141,652

9

Balance Sheet Reclassification

Under Topic 605, the gross amount of accrued revenue reserves for price adjustments and other revenue reserves of $141.7 million was included within accounts receivable, net as of June 30, 2018. Subsequent to the adoption of Topic 606, such balances are presented on a gross basis as accrued price adjustments and other revenue reserves of $141.7 million, which is presented in the price adjustment and other revenue reserves balance sheet caption.

The adoption of Topic 606 has no impact on the total cash flows from operating, investing, or financing activities on the Condensed Consolidated Statements of Cash Flows.

The following table summarizes the impacts of adopting Topic 606 on the Company’s Condensed Consolidated Balance Sheet as of March 30, 2019 (in thousands):

	As Reported		If Reported Under Topic 605		Effect of Adoption of Topic 606
Accounts receivable, net	$	381,152	$	275,141	$	106,011
Price adjustment and other revenue reserves	106,011		—		106,011

Practical Expedients and Elections

• The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which the Company recognizes revenue at the amount to which it has the right to invoice for services performed.

• The Company has elected to account for shipping and handling costs as fulfillment costs after the customer obtains control of the goods.

• The Company has elected to exclude sales, use, value added, and some excise taxes, if applicable, from the measurement of the transaction price. 

Updated Revenue Recognition Policy

The Company recognizes revenue for sales to direct customers and distribution customers ("distributors") when a customer obtains control of promised goods or services in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. The transaction price is calculated as selling price net of variable considerations, such as distributor price adjustments. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it is expected to be entitled. The transaction price does not include amounts collected on behalf of another party, such as sales taxes or value added tax. The Company elected the practical expedient to not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company estimates returns for sales to direct customers and distributors based on historical return rates applied against current period gross revenue. Specific customer returns and allowances are considered within this estimate.

Accounts receivable from direct customers and distributors are recognized and inventory is relieved upon shipment as title to inventories generally transfers upon shipment, at which point the Company has a legally enforceable right to collection under normal terms. Accounts receivable related to consigned inventory is recognized when the customer takes title to such inventory from its consigned location, at which point inventory is relieved, title transfers, and the Company has a legally enforceable right to collection under the terms of the agreement with the related customers. Customers are generally required to pay for products and services within the Company’s standard terms, which is net 30 days from the date of invoice. The Company does not have any significant financing components greater than one year.

The Company estimates potential future returns and sales allowances related to current period product revenue. Management analyzes historical returns, changes in customer demand and acceptance of products when evaluating the adequacy of returns and sales allowances. Estimates made may differ from actual returns and sales allowances. These differences may materially impact reported revenue and amounts ultimately collected on accounts receivable. Historically, such differences have not been material.

10

Distributor price adjustments are estimated based on the Company's historical experience rates and also considering economic conditions and contractual terms. To date, actual distributor claims activity has been materially consistent with the estimates that the Company has made based on its historical rates.

The Company's revenue arrangements do not contain significant financing components. Revenue is recognized over a period of time when it is assessed that performance obligations are satisfied over a period rather than at a point in time. When any of the following criteria is fulfilled, revenue is recognized over a period of time:

(a) The customer simultaneously receives and consumes the benefits provided by the performance completed.

(b) Performance creates or enhances an asset (for example, work in process) that the customer controls as the asset is created or enhanced.

(c) Performance does not create an asset with an alternative use, and has an enforceable right to payment for performance completed to date.

In January 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, with further classifications made recently with the issuance of ASU 2018-03 and ASU 2018-04, which provides guidance for the recognition, measurement, presentation, and disclosure of financial assets and liabilities. The application of this ASU was made by the means of a cumulative-effect adjustment to the balance sheet for the equity securities that qualify for the practical expedient to estimate fair value using the net asset value per share. The amendments related to equity securities without readily determinable fair values (including disclosure requirements) is being applied prospectively to equity investments that exist as of the date of adoption. The Company adopted ASU 2016-01 in the first quarter of fiscal year 2019. As a result of this adoption, the Company recognized an increase of $2.5 million, net of tax, in retained earnings at the beginning of fiscal year 2019.

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory. ASU 2016-16 requires that entities recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs instead of when the asset is sold. The Company adopted ASU 2016-16 in the first quarter of fiscal year 2019. The adoption of this guidance did not have an impact on the Company's consolidated financial statements.

In March 2017, the FASB issued ASU 2017-07, Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, which requires employers that offer or maintain defined benefit plans to disaggregate the service component from the other components of net benefit cost and provides guidance on presentation of the service component and the other components of net benefit cost in the statement of operations. The application of ASU 2017-07 requires retrospective basis for all periods presented. The Company adopted ASU 2017-07 in the first quarter of fiscal year 2019. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.

In May 2017, the FASB issued ASU 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. The amendments in this standard provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. Unless the changes in terms or conditions meet all three criteria outlined in the guidance, modification accounting should be applied. The three criteria relate to changes in the terms and conditions that affect the fair value, vesting conditions, or classification of a share-based payment award. The guidance is required to be applied prospectively to an award modified on or after the adoption date. The Company adopted ASU 2017-09 in the first quarter of fiscal year 2019. The adoption of this guidance did not have an impact on the Company's consolidated financial statements.

In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. This standard provides guidance about the reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act. The Company adopted ASU 2018-02 in the first quarter of fiscal year 2019. There was no material change to the Company's consolidated financial statements as a result of this adoption.

In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Non-employee Share-Based Payment Accounting. This ASU largely aligns the accounting for share-based payment awards to employees and non-employees. Under the new guidance, both sets of awards, for employees and non-employees, will essentially follow the same model, with small discrepancies related to the term assumption when valuing non-employee awards. The Company adopted ASU 2018-07 in the first quarter of fiscal year 2019. The adoption of this guidance did not have an impact on the Company's consolidated financial statements.

11

SEC Disclosure Update and Simplification. In August 2018, the SEC adopted a final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, which amends certain disclosure requirements that were redundant and outdated. The rule also requires registrants to include in their interim financial statements a reconciliation of changes in stockholders' equity in the notes or as a separate statement. The final rule was effective on November 5, 2018. The Company has adopted the final rule as of December 29, 2018, and has included a reconciliation of the changes in stockholders' equity in this Form 10-Q.

(ii) Recent Accounting Updates Not Yet Effective

In February 2016, the FASB issued ASU 2016-02, Leases and subsequent amendments to the initial update: ASU 2017-13, ASU 2018-01, ASU 2018-11, ASU 2018-20 and ASU 2019-01 (collectively, Topic 842), which supersede the lease accounting requirements in Topic 840. Topic 842 requires a dual approach for lessee accounting under which a lessee would account for leases as finance leases or operating leases. Both finance leases and operating leases will result in the lessee recognizing a right-of-use asset and a corresponding lease liability. For finance leases, the lessee would recognize interest expense and amortization of the right-of-use asset, and for operating leases, the lessee would recognize a straight-line total lease expense. The guidance also requires qualitative and specific quantitative disclosures to supplement the amounts recorded in the financial statements so that users can understand more about the nature of an entity’s leasing activities, including significant judgments and changes in judgments. This guidance is effective beginning in the first quarter of fiscal year 2020 on a modified retrospective approach. The Company is currently evaluating the potential impact of this standard on its consolidated financial statements and expects that there will be a material increase in assets and liabilities on the Consolidated Balance Sheets at adoption due to the recognition of right-of-use assets and related lease liabilities. Upon adoption, the Company expects that its financial statement disclosures will be expanded to present additional details of its leasing arrangements.

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which improves disclosures by removing, modifying and adding disclosure requirements related to fair value measurements. The update highlights adjustments in disclosures for changes in the fair value of Level 1, Level 2, and Level 3 instruments. This guidance is effective beginning in the first quarter of fiscal year 2021, with early adoption permitted. The Company does not believe that this update will have a material impact on its consolidated financial statements.

NOTE 3: BALANCE SHEET COMPONENTS

Inventories consist of:

	March 30, 2019		June 30, 2018
Inventories:	(in thousands)
Raw materials	$	18,799	$	16,251
Work-in-process	172,020		173,859
Finished goods	82,013		92,280
	$	272,832	$	282,390

Property, plant and equipment, net consists of:

	March 30, 2019			June 30, 2018
Property, plant and equipment, net:	(in thousands)
Land	$	17,731		$	17,731
Buildings and building improvements	258,642			254,733
Machinery, equipment and software	1,358,892			1,309,487
	1,635,265			1,581,951
Less: accumulated depreciation	(1,063,310		)	(1,002,587		)
	$	571,955		$	579,364

12

Accrued salary and related expenses consist of:

	March 30, 2019		June 30, 2018
Accrued salary and related expenses:	(in thousands)
Accrued vacation	$	28,831	$	30,695
Accrued bonus	56,187		92,288
Accrued salaries	13,711		8,210
ESPP withholding	15,634		5,158
Accrued fringe benefits	8,075		4,752
Other	5,927		10,579
	$	128,365	$	151,682

NOTE 4: FAIR VALUE MEASUREMENTS

The FASB established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Three levels of inputs that may be used to measure fair value are as follows:

Level 1 - Quoted (unadjusted) prices in active markets for identical assets or liabilities.

The Company’s Level 1 assets consist of money market funds.

Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.

The Company’s Level 2 assets and liabilities consist of U.S. Treasury securities, agency securities, corporate debt securities, certificates of deposit, commercial paper and foreign currency forward contracts that are valued using quoted market prices or are determined using a yield curve model based on current market rates.

Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

The Company's Level 3 assets and liabilities consist of acquisition related contingent consideration liabilities.

13

Assets and liabilities measured at fair value on a recurring basis were as follows:

	As of March 30, 2019								As of June 30, 2018
	Fair Value  Measurements Using						Total Balance		Fair Value  Measurements Using						Total Balance
	Level 1		Level 2		Level 3				Level 1		Level 2		Level 3
	(in thousands)
Assets
Cash and cash equivalents
Agency securities	$	—	$	—	$	—	$	—	$	—	$	13,946	$	—	$	13,946
Certificates of deposit	—		—		—		—		—		6,000		—		6,000
Commercial paper	—		—		—		—		—		45,063		—		45,063
Corporate debt securities	—		—		—		—		—		3,819		—		3,819
Money market funds	195,805		—		—		195,805		98,467		—		—		98,467
U.S. Treasury securities	—		—		—		—		—		30,988		—		30,988
Short term investments
Certificates of deposit	—		5,000		—		5,000		—		52,428		—		52,428
Commercial paper	—		2,999		—		2,999		—		64,354		—		64,354
Corporate debt securities	—		185,994		—		185,994		—		367,765		—		367,765
U.S. Treasury securities	—		49,871		—		49,871		—		598,368		—		598,368
Other current assets
Foreign currency forward contracts	—		230		—		230		—		235		—		235
Total assets	$	195,805	$	244,094	$	—	$	439,899	$	98,467	$	1,182,966	$	—	$	1,281,433
Liabilities
Accrued expenses
Foreign currency forward contracts	$	—	$	496	$	—	$	496	$	—	$	1,845	$	—	$	1,845
Contingent consideration	—		—		9,052		9,052		—		—		8,000		8,000
Other liabilities
Contingent consideration	—		—		—		—		—		—		8,000		8,000
Total Liabilities	$	—	$	496	$	9,052	$	9,548	$	—	$	1,845	$	16,000	$	17,845

During the nine months ended March 30, 2019 and the year ended June 30, 2018, there were no transfers in or out of Level 3 from other levels in the fair value hierarchy.

There were no assets or liabilities measured at fair value on a non-recurring basis as of March 30, 2019 and June 30, 2018 other than impairments of long-lived assets. The Company uses various inputs to evaluate investments in privately held companies, including valuations of recent financing events as well as other relevant information regarding the performance of the issuer. There were no material impairments of long-lived assets in any of the periods presented.

14

NOTE 5: FINANCIAL INSTRUMENTS

Short-term investments

Fair values were as follows:

	March 30, 2019									June 30, 2018
	Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Estimated Fair Value		Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Estimated Fair Value
	(in thousands)
Available-for-sale investments
Certificates of deposit	$	5,000	$	—	$	—		$	5,000	$	52,429	$	—	$	(1	)	$	52,428
Commercial paper	2,999		—		—			2,999		64,354		—		—			64,354
Corporate debt securities	186,446		21		(473		)	185,994		369,734		39		(2,008		)	367,765
U.S. Treasury securities	49,973		—		(102		)	49,871		600,068		10		(1,710		)	598,368
Total available-for-sale investments	$	244,418	$	21	$	(575	)	$	243,864	$	1,086,585	$	49	$	(3,719	)	$	1,082,915

In the three and nine months ended March 30, 2019 and June 30, 2018, the Company did not recognize any impairment charges on short-term investments. All available-for-sale investments have maturity dates between April 1, 2019 and March 12, 2021.

The Company invests in various financial instruments including U.S. Treasury securities, corporate debt securities, commercial paper, and certificates of deposit which include instruments issued or managed by industrial, financial, and utility institutions and U.S. Treasury securities which include U.S. government Treasury bills and Treasury notes.

Derivative instruments and hedging activities

The Company incurs expenditures denominated in non-U.S. currencies, primarily the Philippine Peso and the Thai Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and the European Euro, Indian Rupee, Japanese Yen, Taiwan New Dollar, South Korean Won, Chinese Yuan and Canadian Dollar, for sales offices and research and development activities undertaken outside of the U.S.

The Company has established a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effects of certain foreign currency exposures. The Company does not use these foreign currency forward contracts for trading purposes.

Derivatives designated as cash flow hedging instruments

The Company designates certain forward contracts as hedging instruments pursuant to Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging (“ASC 815”). As of March 30, 2019 and June 30, 2018, the notional amounts of the forward contracts the Company held to purchase international currencies were $44.4 million and $49.7 million, respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $0 and $1.2 million, respectively.

Derivatives not designated as hedging instruments

As of March 30, 2019 and June 30, 2018, the notional amounts of the forward contracts the Company held to purchase international currencies were $19.9 million and $21.1 million, respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $21.9 million and $21.3 million, respectively. The Company's foreign currency forward contract gains or losses included in the Condensed Consolidated Statements of Income were not material for the three and nine months ended March 30, 2019 and March 31, 2018.

15

Effect of hedge accounting on the Condensed Consolidated Statements of Income

The following tables summarize the gains (losses) from hedging activities recognized in the Company's Condensed Consolidated Statements of Income:

	Three Months Ended							Nine Months Ended
	March 30, 2019							March 30, 2019
	Net Revenue		Cost of Goods Sold		Operating Expenses				Net Revenue		Cost of Goods Sold			Operating Expenses
	(in thousands)
Income and expenses line items in which the effects of cash flow hedges are recorded	$	542,383	$	201,552	$	183,691			$	1,757,784	$	613,669		$	570,588
Gain (loss) on cash flow hedges:
Foreign exchange contracts:
Gain (loss) reclassified from accumulated other comprehensive income into income	$	6	$	261	$	(79	)		$	50	$	(335	)	$	(1,906	)

	Three Months Ended							Nine Months Ended
	March 31, 2018							March 31, 2018
	Net Revenue			Cost of Goods Sold		Operating Expenses			Net Revenue			Cost of Goods Sold		Operating Expenses
	(in thousands)
Income and expenses line items in which the effects of cash flow hedges are recorded	$	648,599		$	224,653	$	199,108		$	1,846,913		$	639,460	$	596,401
Gain (loss) on cash flow hedges:
Foreign exchange contracts:
Gain (loss) reclassified from accumulated other comprehensive income into income	$	(11	)	$	165	$	356		$	(64	)	$	116	$	1,781

Outstanding debt obligations

The following table summarizes the Company’s outstanding debt obligations:

	March 30, 2019			June 30, 2018
	(in thousands)
3.45% fixed rate notes due June 2027	$	500,000		$	500,000
2.5% fixed rate notes due November 2018	—			500,000
3.375% fixed rate notes due March 2023	500,000			500,000
Total outstanding debt	1,000,000			1,500,000
Less: Current portion (included in "Current portion of debt")	—			(499,406		)
Less: Reduction for unamortized discount and debt issuance costs	(7,775		)	(9,447		)
Total long-term debt	$	992,225		$	991,147

On June 15, 2017, the Company completed a public offering of $500 million aggregate principal amount of the Company's 3.45% senior unsecured and unsubordinated notes due in June 2027 (“2027 Notes”), with an effective interest rate of 3.5%. Interest on

16

the 2027 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, commencing on December 15, 2017. The net proceeds of this offering were approximately $495.2 million, after issuing at a discount and deducting paid expenses.

On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% coupon senior unsecured and unsubordinated notes due in November 2018 (“2018 Notes”), with an effective interest rate of 2.6%. Interest on the 2018 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing on May 15, 2014. The net proceeds of this offering were approximately $494.5 million, after issuing at a discount and deducting paid expenses. In November of 2018, the Company repaid the entire $500 million in principal and any outstanding interest, related to these outstanding notes.

On March 18, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 3.375% senior unsecured and unsubordinated notes due in March 2023 (“2023 Notes”), with an effective interest rate of 3.5%. Interest on the 2023 Notes is payable semi-annually in arrears on March 15 and September 15 of each year. The net proceeds of this offering were approximately $490.0 million, after issuing at a discount and deducting paid expenses.

The debt indentures that govern the 2027 Notes and the 2023 Notes include covenants that limit the Company's ability to grant liens on its facilities and to enter into sale and leaseback transactions, which could limit the Company's ability to secure additional debt funding in the future. In circumstances involving a change of control of the Company followed by a downgrade of the rating of the 2027 Notes or the 2023 Notes, the Company would be required to make an offer to repurchase the affected notes at a purchase price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest.

The Company accounts for all the notes above based on their amortized cost. The discount and expenses are being amortized to Interest and other income (expense), net in the Condensed Consolidated Statements of Income over the life of the notes. The interest expense is recorded in Interest and other income (expense), net in the Condensed Consolidated Statements of Income. Amortized discount and expenses, as well as interest expense associated with the notes, were $8.9 million and $12.4 million during the three months ended March 30, 2019 and March 31, 2018, respectively. Amortized discount and expenses, as well as interest expense associated with the notes, were $32.5 million and $37.1 million during the nine months ended March 30, 2019 and March 31, 2018, respectively.

The estimated fair value of the Company’s outstanding debt obligations was approximately $985 million as of March 30, 2019. The estimated fair value of the debt is based primarily on observable market inputs and is a Level 2 measurement.

The Company recorded interest expense of $9.3 million and $12.4 million during the three months ended March 30, 2019, and March 31, 2018, respectively. The Company recorded interest expense of $33.9 million and $37.6 million during the nine months ended March 30, 2019 and March 31, 2018, respectively.

Other Financial Instruments

For the balance of the Company’s financial instruments, cash equivalents, accounts receivable, accounts payable and other accrued liabilities, the carrying amounts approximate fair value due to their short maturities.

NOTE 6: STOCK-BASED COMPENSATION

At March 30, 2019, the Company had one stock incentive plan, the Company's 1996 Stock Incentive Plan (the “1996 Plan”) and one employee stock purchase plan, the 2008 Employee Stock Purchase Plan (the “2008 ESPP”). The 1996 Plan was adopted by the Board of Directors to provide the grant of incentive stock options, non-statutory stock options, restricted stock units (“RSUs”), and market stock units (“MSUs”) to employees, directors, and consultants.

Pursuant to the 1996 Plan, the exercise price for incentive stock options and non-statutory stock options is determined to be the fair market value of the underlying shares on the date of grant. Options typically vest ratably over a four-year period measured from the date of grant. Options generally expire no later than seven years after the date of grant, subject to earlier termination upon an optionee's cessation of employment or service.

RSUs granted to employees typically vest ratably over a four-year period and are converted into shares of the Company's common stock upon vesting, subject to the employee's continued service to the Company over that period. RSUs granted after August 2017 will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements.

MSUs granted to employees typically vest over a four-year cliff period and are converted into shares of the Company's common stock upon vesting, subject to the employee's continued service to the Company over that period. The number of shares that are

17

released at the end of the performance period can range from zero to a maximum cap depending on the Company's performance. MSUs granted after August 2017 will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements.

The following tables show total stock-based compensation expense by type of award, and the resulting tax effect, included in the Condensed Consolidated Statements of Income for the three and nine months ended March 30, 2019 and March 31, 2018, respectively:

	Three Months Ended
	March 30, 2019								March 31, 2018
	Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total		Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total
	(in thousands)
Cost of goods sold	$	8	$	1,951	$	654	$	2,613	$	35	$	2,003	$	537	$	2,575
Research and development	5		9,399		1,658		11,062		13		8,725		1,339		10,077
Selling, general and administrative	64		8,184		897		9,145		51		7,218		684		7,953
Pre-tax stock-based compensation expense	$	77	$	19,534	$	3,209	$	22,820	$	99	$	17,946	$	2,560	$	20,605
Less: income tax effect							1,946								2,053
Net stock-based compensation expense							$	20,874							$	18,552

	Nine Months Ended
	March 30, 2019								March 31, 2018
	Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total		Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total
	(in thousands)
Cost of goods sold	$	28	$	5,597	$	1,656	$	7,281	$	196	$	5,783	$	1,482	$	7,461
Research and development	27		26,783		3,948		30,758		507		24,212		3,342		28,061
Selling, general and administrative	178		24,600		2,156		26,934		636		21,004		1,770		23,410
Pre-tax stock-based compensation expense	$	233	$	56,980	$	7,760	$	64,973	$	1,339	$	50,999	$	6,594	$	58,932
Less: income tax effect							6,214								6,830
Net stock-based compensation expense							$	58,759							$	52,102

The expenses included in the Condensed Consolidated Statements of Income for RSUs include expenses related to MSUs of $3.0 million and $2.2 million for the three months ended March 30, 2019 and March 31, 2018, respectively, and $8.3 million and $5.8 million for the nine months ended March 30, 2019 and March 31, 2018, respectively.

Stock Options

The fair value of options granted to employees under the 1996 Plan is estimated on the date of grant using the Black-Scholes option valuation model.

There were no stock options granted in the three and nine months ended March 30, 2019 and March 31, 2018.

The following table summarizes outstanding, exercisable and vested and expected to vest stock options as of March 30, 2019 and related activity for the nine months ended March 30, 2019:

18

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value(1)
Balance at June 30, 2018	1,688,253		$	27.72
Options Granted	—		—
Options Exercised	(699,416	)	27.13
Options Cancelled	(3,439	)	28.08
Balance at March 30, 2019	985,398		$	28.14	1.3	$	25,692,173
Exercisable, March 30, 2019	985,398		$	28.14	1.3	$	25,692,173
Vested and expected to vest, March 30, 2019	985,398		$	28.14	1.3	$	25,692,173

(1) Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of March 30, 2019.

As of March 30, 2019, there was no unrecognized stock compensation from unvested stock options.

Restricted Stock Units and Other Awards

The fair value of RSUs and other awards under the Company’s 1996 Plan is estimated using the value of the Company’s common stock on the date of grant, reduced by the present value of dividends expected to be paid on the Company’s common stock prior to vesting. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis.

The weighted-average fair value of RSUs and other awards granted was $51.01 and $54.81 per share for the three months ended March 30, 2019 and March 31, 2018, respectively, and $54.04 and $44.49 per share for the nine months ended March 30, 2019 and March 31, 2018, respectively.

The following table summarizes the outstanding and expected to vest RSUs and other awards as of March 30, 2019 and related activity during the nine months ended March 30, 2019:

	Number of Shares		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value(1)
Balance at June 30, 2018	5,524,432
Restricted stock units and other awards granted	1,614,379
Restricted stock units and other awards released	(1,377,399	)
Restricted stock units and other awards cancelled	(458,762	)
Balance at March 30, 2019	5,302,650		2.7	$	287,456,657
Outstanding and expected to vest, March 30, 2019	4,439,502		2.7	$	240,665,404

(1) Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of March 30, 2019.

The Company withheld shares totaling $23.0 million in value as a result of employee withholding taxes based on the value of RSUs on vesting date for the nine months ended March 30, 2019. Total payments for employees’ tax obligations to taxing authorities are reflected as financing activities within the Condensed Consolidated Statements of Cash Flows.

As of March 30, 2019, there was $162.6 million of unrecognized compensation expense related to 5.3 million unvested RSUs and other awards, which is expected to be recognized over a weighted average period of approximately 2.7 years.

Market Stock Units (MSUs)

19

The Company grants MSUs to senior members of management in lieu of granting stock options. For MSUs granted prior to September 2017, the performance metrics of this program are based on relative performance of the Company’s stock price as compared to the Semiconductor Exchange Traded Fund index SPDR S&P (the “XSD”). For MSUs granted in September 2017 and after, the performance metrics for this program are based on the total shareholder return ("TSR") of the Company relative to the TSR of the other companies included in the XSD. The fair value of MSUs is estimated using a Monte Carlo simulation model on the date of grant. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis. Compensation expense is recognized based on the initial valuation and is not subsequently adjusted as a result of the Company’s performance relative to that of the XSD or the TSR of the companies included in the XSD, as applicable. Vesting for MSUs is contingent upon both service and market conditions and has a four-year vesting cliff period. MSUs granted after August 2017 vest based upon annual performance and are subject to continued service through the end of the four-year period, but will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements.

The weighted-average fair value of MSUs granted was $75.48 and $51.03 per share for the nine months ended March 30, 2019 and March 31, 2018, respectively.

The following table summarizes the number of MSUs outstanding and expected to vest as of March 30, 2019 and their activity during the nine months ended March 30, 2019:

	Number of Shares		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value(1)
Balance at June 30, 2018	1,079,064
Market stock units granted	247,804
Market stock units released	(13,594	)
Market stock units cancelled	(264,742	)
Balance at March 30, 2019	1,048,532		2.7	$	56,840,920
Outstanding and expected to vest, March 30, 2019	976,524		2.7	$	52,937,345

(1) Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of March 30, 2019.

As of March 30, 2019, there was $31.3 million of unrecognized compensation expense related to 1.0 million unvested MSUs, which is expected to be recognized over a weighted average period of approximately 2.7 years.

Employee Stock Purchase Plan

Employees are granted rights to acquire common stock under the 2008 ESPP.

The fair value of 2008 ESPP rights granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model using the following assumptions for the offering periods outstanding:

	Three Months Ended		Nine Months Ended
	March 30, 2019	March 31, 2018	March 30, 2019	March 31, 2018
Expected holding period (in years)	0.5 years	0.5 years	0.5 years	0.5 years
Risk-free interest rate	2.4% - 2.6%	1.1% - 1.5%	1.6% - 2.6%	0.8% - 1.5%
Expected stock price volatility	27.5 % - 28.9%	20.5% - 20.7%	19.6% - 32.7 %	19.1% - 24.7%
Dividend yield	2.8% - 3.1%	3.0% - 3.1%	2.8% - 3.1%	3.0% - 3.4%

As of March 30, 2019, there was $5.3 million of unrecognized compensation expense related to the 2008 ESPP.

NOTE 7: EARNINGS PER SHARE

Basic earnings per share are computed using the weighted average number of shares of common stock outstanding during the period. For purposes of computing basic earnings per share, the weighted average number of outstanding shares of common stock

20

excludes unvested RSUs and other awards as well as MSUs. Diluted earnings per share incorporates the incremental shares issuable upon the assumed exercise of stock options, assumed release of unvested RSUs and other awards as well as MSUs, and assumed issuance of common stock under the 2008 ESPP using the treasury stock method.

The following table sets forth the computation of basic and diluted earnings per share:

	Three Months Ended				Nine Months Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
	(in thousands, except per share data)
Numerator for basic earnings per share and diluted earnings per share
Net income	$	130,613	$	193,627	$	459,928	$	273,146
Denominator for basic earnings per share	273,221		280,850		275,831		281,525
Effect of dilutive securities:
Stock options, ESPP, RSUs, and MSUs	3,389		5,031		3,849		4,696
Denominator for diluted earnings per share	276,610		285,881		279,680		286,221
Earnings per share
Basic	$	0.48	$	0.69	$	1.67	$	0.97
Diluted	$	0.47	$	0.68	$	1.64	$	0.95

For the three months ended March 30, 2019 and March 31, 2018, and the nine months ended March 30, 2019 and March 31, 2018, no stock awards were determined to be anti-dilutive. Therefore, none were excluded from the calculation of diluted earnings per share.

NOTE 8: SEGMENT INFORMATION

The Company designs, develops, manufactures and markets a broad range of linear and mixed signal integrated circuits. All of the Company's products are designed through a centralized R&D function, manufactured using centralized manufacturing (internal and external), and sold through a centralized sales force and shared wholesale distributors.

The Company currently has one operating segment and reportable segment. In accordance with ASC No. 280, Segment Reporting (“ASC 280”), the Company considers operating segments to be components of the Company’s business for which separate financial information is available that is evaluated regularly by the Company’s Chief Operating Decision Maker in deciding how to allocate resources and in assessing performance. The Chief Operating Decision Maker for the Company was assessed and determined to be the CEO. The CEO reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, the Company has determined that it has a single operating and reportable segment.

Enterprise-wide information is provided in accordance with ASC 280. Geographical revenue information is based on customers’ ship-to location. Long-lived assets consist of property, plant and equipment. Property, plant and equipment information is based on the physical location of the assets at the end of each fiscal year.

21

Net revenues from unaffiliated customers by geographic region were as follows:

	Three Months Ended				Nine Months Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
	(in thousands)
United States	$	63,970	$	75,760	$	200,944	$	223,021
China	183,753		219,160		611,768		662,114
Rest of Asia	176,396		222,207		583,616		586,109
Europe	104,124		114,254		316,155		329,939
Rest of World	14,140		17,218		45,301		45,730
	$	542,383	$	648,599	$	1,757,784	$	1,846,913

Net long-lived assets by geographic region were as follows:

	March 30, 2019		June 30, 2018
	(in thousands)
United States	$	359,743	$	361,432
Philippines	110,214		120,657
Rest of World	101,998		97,275
	$	571,955	$	579,364

NOTE 9: COMPREHENSIVE INCOME (LOSS)

The changes in accumulated other comprehensive income (loss) by component and related tax effects in the nine months ended March 30, 2019 and March 31, 2018 were as follows:

(in thousands)	Unrealized Gains and (Losses) on Intercompany Receivables			Unrealized Gains and (Losses) on Post-Retirement Benefits			Cumulative Translation Adjustment			Unrealized Gains and (Losses) on Cash Flow Hedges			Unrealized Gains and (Losses) on Available-For-Sale Securities			Total
June 30, 2018	$	(6,280	)	$	(2,516	)	$	(1,136	)	$	(1,383	)	$	(3,670	)	$	(14,985	)
Other comprehensive income (loss) before reclassifications	—			—			—			(783		)	3,247			2,464
Amounts reclassified out of accumulated other comprehensive loss (income)	—			292			—			2,191			—			2,483
Tax effects	—			(60		)				(241		)	(131		)	(432		)
Other comprehensive income, net	—			232			—			1,167			3,116			4,515
March 30, 2019	$	(6,280	)	$	(2,284	)	$	(1,136	)	$	(216	)	$	(554	)	$	(10,470	)

22

(in thousands)	Unrealized Gains and (Losses) on Intercompany Receivables			Unrealized Gains and (Losses) on Post-Retirement Benefits			Cumulative Translation Adjustment			Unrealized Gains and (Losses) on Cash Flow Hedges			Unrealized Gains and (Losses) on Available-For-Sale Securities			Total
June 24, 2017	$	(6,280	)	$	(1,258	)	$	(1,136	)	$	18		$	(1,234	)	$	(9,890	)
Other comprehensive income (loss) before reclassifications	—			—			—			2,012			(3,707		)	(1,695		)
Amounts reclassified out of accumulated other comprehensive loss (income)	—			154			—			(1,834		)	—			(1,680		)
Tax effects	—			(168		)	—			(45		)	274			61
Other comprehensive income (loss), net	—			(14		)	—			133			(3,433		)	(3,314		)
March 31, 2018	$	(6,280	)	$	(1,272	)	$	(1,136	)	$	151		$	(4,667	)	$	(13,204	)

NOTE 10: INCOME TAXES

In the three and nine months ended March 30, 2019, the Company recorded an income tax provision of $29.8 million and $116.8 million, respectively, compared to $28.7 million and $328.0 million for the three and nine months ended March 31, 2018, respectively. The Company’s effective tax rate for the three and nine months ended March 30, 2019 was 18.6% and 20.3%, respectively, compared to the 12.9% and 54.6% for the three and nine months ended March 31, 2018, respectively.

On December 22, 2017 legislation, commonly referred to as the Tax Cuts and Jobs Act (the “Act”), was enacted. The Act included a one-time tax on accumulated unremitted earnings of our foreign subsidiaries (“Transition Tax”). SEC Staff Accounting Bulletin No. 118 allowed the use of provisional amounts (reasonable estimates) if accounting for the income tax effects of the Act was not completed. Provisional amounts must be adjusted within a one-year measurement period from the enactment date of the Act. In the second quarter of fiscal year 2018, the Company recorded a discrete $236.9 million provisional Transition Tax charge. During the measurement period, the Company gathered information and analyzed available guidance to more precisely compute the amount of the Transition Tax. In the second quarter of fiscal year 2019 the Company completed this work and recorded a discrete $22.1 million measurement period adjustment for the Transition Tax, which increased the Company’s effective tax rate for the nine months ended March 30, 2019 by 3.8%. As of the end of the second quarter of fiscal year 2019, the accounting for income tax effects of the Act has been completed.

The Act reduced the federal statutory tax rate from 35% to 21%, effective January 1, 2018, which resulted in a fiscal year 2018 federal statutory tax rate of 28.1% for the Company (average of a 35% rate for the first half of fiscal year 2018 and a 21% rate for the second half of fiscal year 2018). The Company’s federal statutory tax rate for fiscal year 2019 is 21%. In the second quarter of fiscal year 2018, the Company recorded a $13.7 million discrete charge to remeasure deferred tax assets and liabilities as of the enactment date of the Act to reflect the federal statutory tax rate reductions.

The Act included Global Intangible Low-Taxed Income (“GILTI”) provisions, which first impact the Company in fiscal year 2019. The GILTI provisions effectively subject income earned by the Company’s foreign subsidiaries to current U.S. tax at a rate of 10.5%, less foreign tax credits. The Company has elected to treat tax generated by the GILTI provisions as a period expense.

The Company’s federal statutory tax rate for fiscal year 2019 is 21%. The Company’s effective tax rate for the three months ended March 30, 2019 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by tax generated by the GILTI provisions, a $4.1 million discrete charge for differences between the Company's fiscal year 2018 tax returns and the tax provision originally recorded, and $5.7 million of discrete interest accruals for unrecognized tax benefits.

The Company’s effective tax rate for the nine months ended March 30, 2019 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by $21.0 million of discrete charges for the Transition Tax, tax generated by the GILTI provisions, $15.1 million of discrete interest accruals for unrecognized tax benefits, and $4.8 million of discrete charges for differences between the Company's fiscal year 2018 tax returns and the tax provision originally recorded.

23

The Company’s federal statutory tax rate for fiscal year 2018 was 28.1%. The Company’s effective tax rate for the three months ended March 31, 2018, was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, and $4.6 million of discrete excess tax benefits generated by the settlement of share-based awards, partially offset by $5.1 million of discrete interest accruals for unrecognized tax benefits.

The Company’s effective tax rate for the nine months ended March 31, 2018 was higher than the statutory rate primarily due to a $236.9 million discrete provisional charge for the Transition Tax, a $13.7 million discrete charge to remeasure deferred taxes as of the enactment date of the Act, and $13.1 million of discrete interest accruals for unrecognized tax benefits, partially offset by earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates and $8.3 million of discrete excess tax benefits generated by the settlement of share-based awards.

The Company engages in continuous discussions and negotiations with tax authorities regarding tax matters in various jurisdictions. It is reasonably possible that gross unrecognized tax benefits, including accrued interest and penalties, could decrease up to $448 million within the next twelve months, primarily due to the completion of federal tax audits, including any administrative appeals. The $448 million primarily relates to matters involving federal taxation of cross-border transactions.

The Company’s federal corporate income tax returns are audited on a recurring basis by the Internal Revenue Service (“IRS”). The IRS concluded its field examination of the Company’s federal corporate income tax returns for fiscal years 2009 through 2011 and issued an IRS Revenue Agent's Report in July 2016 that included proposed adjustments for transfer pricing issues related to cost sharing and buy-in license payments for the use of intangible property by one of the Company’s international subsidiaries. The Company disagreed with the proposed transfer pricing adjustments and related penalties, and in September 2016, the Company filed a protest to challenge the proposed adjustments and request a conference with the Appeals Office of the IRS. In May 2018, a preliminary understanding was reached with the IRS regarding the contested issues for the audit and post-audit years, which the Company expects may be finalized in fiscal year 2019 with the execution of a closing agreement. In June 2018, the Company made advance payments for audit and post-audit years tax of $140.7 million and interest of $37.4 million. These payments will reduce the accrual of interest on audit and post-audit years tax deficiencies that would be owed if the preliminary understanding is finalized. The Company’s reserves for unrecognized tax benefits are sufficient to cover the audit and post-audit years tax deficiencies that would be owed as a result of the preliminary understanding. In fiscal year 2017, the IRS commenced an audit of the Company’s federal corporate income tax returns for fiscal years 2012 through 2014, which is ongoing. In the first quarter of fiscal year 2019, the Company was notified that the IRS will commence an audit of the Company's federal corporate income tax returns for fiscal years 2015 through 2016.

NOTE 11: COMMITMENTS AND CONTINGENCIES

Legal Proceedings

The Company is party or subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, including proceedings and claims that relate to intellectual property matters. While the outcome of these matters cannot be predicted with certainty, the Company does not believe that the outcome of any of these matters, individually or in the aggregate, will result in losses that are materially in excess of amounts already recognized or reserved, if any.

Indemnification

The Company indemnifies certain customers, distributors, suppliers and subcontractors for attorney fees, damages and costs awarded against such parties in certain circumstances in which the Company's products are alleged to infringe third party intellectual property rights, including patents, registered trademarks or copyrights. The terms of the Company's indemnification obligations are generally perpetual from the effective date of the agreement. In certain cases, there are limits on and exceptions to the Company's potential liability for indemnification relating to intellectual property infringement claims.

Pursuant to the Company's charter documents and separate written indemnification agreements, the Company has certain indemnification obligations to its current officers, employees and directors, as well as certain former officers and directors.

NOTE 12: COMMON STOCK REPURCHASES

On July 20, 2017, the Board of Directors of the Company authorized the repurchase of up to $1 billion of the Company's common stock. The stock repurchase authorization did not have an expiration date and the pace of repurchase activity depended on factors such as current stock price, levels of cash generation from operations, cash requirements, and other factors. All prior repurchase

24

authorizations by the Company’s Board of Directors for the repurchase of common stock were cancelled and superseded by this repurchase authorization.

On October 30, 2018, the Board of Directors of the Company authorized the repurchase of up to $1.5 billion of the Company’s common stock. The stock repurchase authorization does not have an expiration date and the pace of repurchase activity will depend on factors such as current stock price, levels of cash generation from operations, cash requirements, and other factors. All prior repurchase authorizations by the Company’s Board of Directors for the repurchase of common stock were cancelled and superseded by this repurchase authorization.

During the nine months ended March 30, 2019, the Company repurchased approximately 8.0 million shares of its common stock for $437.0 million. As of March 30, 2019, the Company had remaining authorization of $1.2 billion for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company’s common stock and general market and business conditions.

NOTE 13: ACQUISITION

On January 26, 2018, the Company acquired a privately-held corporation specializing in the development of high-performance USB and video extension technology. Total cash consideration paid in connection with this acquisition was $57.8 million, net of cash acquired. The Company also agreed to pay up to an additional $16.0 million if the acquired business achieves certain financial milestones for the annual period ended August 31, 2018 and annual period ending August 31, 2019. Out of the $16.0 million, $8.0 million was paid during the nine months ended March 30, 2019. The acquired assets included $26.0 million of developed technology and $10.5 million of other intangible assets. The Company also recorded $41.9 million of goodwill in connection with this acquisition. The goodwill is not deductible for tax purposes.

NOTE 14: GOODWILL AND INTANGIBLE ASSETS

Goodwill

The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable.

There were no changes to goodwill for the nine months ended March 30, 2019.

No indicators or instances of impairment were identified in the nine months and fiscal year ended March 30, 2019 and June 30, 2018, respectively.

Intangible assets consisted of the following:

	March 30, 2019						June 30, 2018
	Original Cost		Accumulated Amortization		Net		Original Cost		Accumulated Amortization		Net
	(in thousands)
Intellectual property	$	488,846	$	443,020	$	45,826	$	485,465	$	423,869	$	61,596
Customer relationships	116,505		105,229		11,276		116,294		103,217		13,077
Trade name	9,974		8,830		1,144		9,340		8,588		752
Patents	2,500		2,500		—		2,500		2,469		31
Total amortizable purchased intangible assets	617,825		559,579		58,246		613,599		538,143		75,456
In-process research & development (IPR&D)	2,790		—		2,790		2,790		—		2,790
Total purchased intangible assets	$	620,615	$	559,579	$	61,036	$	616,389	$	538,143	$	78,246

25

The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income:

	Three Months Ended				Nine Months Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
	(in thousands)
Cost of goods sold	$	5,368	$	12,101	$	19,151	$	34,305
Intangible asset amortization	756		876		2,285		3,623
Total intangible asset amortization expenses	$	6,124	$	12,977	$	21,436	$	37,928

The following table represents the estimated future amortization expense of intangible assets as of March 30, 2019:

Fiscal Year	Amount
	(in thousands)
Remaining three months of 2019	$	4,793
2020	15,068
2021	13,368
2022	7,689
2023	7,205
Thereafter	10,123
Total intangible assets	$	58,246

26

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Maxim Integrated Products, Inc. (“Maxim Integrated” or the “Company” and also referred to as “we,” “our” or “us”) disclaims any duty to and undertakes no obligation to update any forward-looking statement, whether as a result of new information relating to existing conditions, future events or otherwise or to release publicly the results of any future revisions it may make to forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by federal securities laws. Readers are cautioned not to place undue reliance on such statements, which speak only as of the date of this Quarterly Report on Form 10-Q. Readers should carefully review future reports and documents that the Company files with or furnishes to the SEC from time to time, such as its Annual Reports on Form 10-K, its Quarterly Reports on Form 10-Q, and any Current Reports on Form 8-K.

Overview of Business

Maxim Integrated is incorporated in the state of Delaware. Maxim Integrated designs, develops, manufactures and markets a broad range of linear and mixed-signal integrated circuits, commonly referred to as analog circuits, for a large number of geographically diverse customers. We also provide a range of high-frequency process technologies and capabilities that can be used in custom designs. The analog market is fragmented and characterized by many diverse applications, a great number of product variations and, with respect to many circuit types, relatively long product life cycles. We are a global company with a wafer manufacturing facility in the U.S., testing facilities in the Philippines and Thailand, and sales and circuit design offices around the world. We also utilize third party foundries for manufacturing of our products. The major end-markets in which our products are sold are the Automotive, Communications and Data Center, Computing, Consumer and Industrial markets.

CRITICAL ACCOUNTING POLICIES

The methods, estimates, and judgments we use in applying our most critical accounting policies have a significant impact on the results we report in our financial statements. The Securities and Exchange Commission (“SEC”) has defined the most critical accounting policies as the ones that are most important to the presentation of our financial condition and results of operations, and that require us to make our most difficult and subjective accounting judgments, often as a result of the need to make estimates of matters that are inherently uncertain. Based on this definition, our most critical accounting policies include revenue recognition, which impacts the recording of net revenues; valuation of inventories, which impacts costs of goods sold and gross margins; the assessment of recoverability of long-lived assets, which impacts impairment of long-lived assets; assessment of recoverability of intangible assets and goodwill, which impacts impairment of goodwill and intangible assets; accounting for income taxes, which impacts the income tax provision; and assessment of litigation and contingencies, which impacts charges recorded in cost of goods sold, selling, general and administrative expenses and income taxes. These policies and the estimates and judgments involved are discussed further in the Management’s Discussion and Analysis of Financial Condition in our Annual Report on Form 10-K for the fiscal year ended June 30, 2018. We have other significant accounting policies that either do not generally require estimates and judgments that are as difficult or subjective, or it is less likely that such accounting policies would have a material impact on our reported results of operations for a given period.

Except for the accounting policies and estimates outlined under Part I, Item 1. Financial Statements - Note 2, there have been no material changes during the nine months ended March 30, 2019 to the items that we disclosed as our critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended June 30, 2018.

27

RESULTS OF OPERATIONS

The following table sets forth certain Condensed Consolidated Statements of Income data expressed as a percentage of net revenues for the periods indicated:

	Three Months Ended				Nine Months Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
Net revenues	100.0	%	100.0	%	100.0	%	100.0	%
Cost of goods sold	37.2	%	34.6	%	34.9	%	34.6	%
Gross margin	62.8	%	65.4	%	65.1	%	65.4	%
Operating expenses:
Research and development	19.7	%	17.6	%	18.8	%	18.3	%
Selling, general and administrative	13.7	%	12.5	%	13.3	%	13.0	%
Intangible asset amortization	0.1	%	0.1	%	0.1	%	0.2	%
Impairment of long-lived assets	—	%	—	%	—	%	—	%
Severance and restructuring expenses	0.3	%	0.4	%	0.2	%	0.8	%
Other operating expenses (income), net	—	%	—	%	—	%	(0.1	)%
Total operating expenses	33.8	%	30.6	%	32.4	%	32.2	%
Operating income	29.0	%	34.7	%	32.6	%	33.2	%
Interest and other income (expense), net	0.6	%	(0.4	)%	0.2	%	(0.5	)%
Income before provision for income taxes	29.6	%	34.3	%	32.8	%	32.7	%
Income tax provision (benefit)	5.5	%	4.4	%	6.6	%	17.8	%
Net income	24.1	%	29.9	%	26.2	%	14.9	%

The following table shows stock-based compensation included in the components of the Condensed Consolidated Statements of Income reported above as a percentage of net revenues for the periods indicated:

	Three Months Ended				Nine Months Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
Cost of goods sold	0.5	%	0.4	%	0.4	%	0.4	%
Research and development	2.0	%	1.6	%	1.7	%	1.5	%
Selling, general and administrative	1.7	%	1.2	%	1.5	%	1.3	%
	4.2	%	3.2	%	3.6	%	3.2	%

Net Revenues

Net revenues were $542.4 million and $648.6 million for the three months ended March 30, 2019 and March 31, 2018, respectively. Revenue from consumer products was down by 27%, mainly due to lower shipments in cell phone and home entertainment products, partially offset by higher shipments in wearable products. Revenue from industrial products was down by 18%, mainly due to a decline in shipments of control, automation and automatic test equipment products. Revenue from communications and data center products was down by 22%, due to generally lower shipments of server, network and data center products. These declines were partially offset by an increase in revenue from automotive products. Revenue from automotive products was up by 5%, driven by higher demand for battery management systems and driver assistance content.

Net revenues were$1.8 billionfor both thenine months ended March 30, 2019 and March 31, 2018. Revenue from automotive products was up by 7%, driven by higher demand for battery management systems and driver assistance content. Revenue from communications and data center products was down by 12% due to generally lower shipments of network, server, and data center products. Revenue from industrial products was down by 7%, driven by lower demand for control, automation, security and other industrial products, partially offset by higher demand for USB extension products. Revenue from consumer products was down by 6%, driven by lower demand for cell phone and home entertainment products, partially offset by higher demand for wearable

28

and handheld computing products. The decrease in revenues in these markets was partially driven by the 13-week second quarter of fiscal year 2019, compared to the 14-week second quarter of fiscal year 2018. In addition, there was a one-time incremental $22.0 million of revenue recognized as a result of the sell-in accounting revenue transition during the second quarter of fiscal 2018. 

During both the three months ended March 30, 2019 and March 31, 2018, approximately 88% of net revenues, were derived from customers outside of the United States. While less than 1.0% of our sales are denominated in currencies other than U.S. dollars, we enter into foreign currency forward contracts to mitigate our risks on firm commitments and net monetary assets denominated in foreign currencies. The impact of changes in foreign exchange rates on our revenue and results of operations for the three months ended March 30, 2019 and March 31, 2018 was immaterial.

Gross Margin

Our gross margin percentages were 62.8% and 65.4% for the three months ended March 30, 2019 and March 31, 2018, respectively. Our gross margin decreased by 2.6 percentage points, primarily due to higher inventory reserves.

Our gross margin percentages were 65.1% and 65.4% for the nine months ended March 30, 2019 and March 31, 2018, respectively. Our gross margin decreased by 0.3 percentage points, primarily due to higher inventory reserves.

Research and Development

Research and development expenses were $107.1 million and $114.4 million for the three months ended March 30, 2019 and March 31, 2018, respectively, which represented 19.7% and 17.6% of net revenues for each respective period. The $7.3 million decrease was due to lower salaries and related personnel expenses.

Research and development expenses were $330.1 million and $338.9 million for the nine months ended March 30, 2019 and March 31, 2018, respectively, which represented 18.8% and 18.3% of net revenues for each respective period. The $8.8 million decrease was due to lower salaries and related personnel expenses.

Selling, General and Administrative

Selling, general and administrative expenses were $74.1 million and $81.3 million for the three months ended March 30, 2019 and March 31, 2018, respectively, which represented 13.7% and 12.5% of net revenues for each respective period. The $7.2 million decrease was due to lower salaries and related personnel expenses.

Selling, general and administrative expenses were $233.5 million and $240.3 million for the nine months ended March 30, 2019 and March 31, 2018, respectively, which represented 13.3% and 13.0% of net revenues for each respective period. The $6.8 million decrease was due to lower salaries and related personnel expenses.

Severance and Restructuring Expenses

Severance and restructuring expenses were $1.7 million and $2.3 million for the three months ended March 30, 2019 and March 31, 2018, respectively, which represented 0.3% and 0.4% of net revenues for each respective period. The $0.5 million decrease was primarily due to a decrease in restructuring activities.

Severance and restructuring expenses were $3.9 million and $14.2 million for the nine months ended March 30, 2019 and March 31, 2018, respectively, which represented 0.2% and 0.8% of net revenues for each respective period. The $10.3 million decrease was primarily due to a decrease in restructuring activities.

Provision for Income Taxes

In the three and nine months ended March 30, 2019, the Company recorded an income tax provision of $29.8 million and $116.8 million, respectively, compared to $28.7 million and $328.0 million for the three and nine months ended March 31, 2018, respectively. The Company’s effective tax rate for the three and nine months ended March 30, 2019 was 18.6% and 20.3%, respectively, compared to 12.9% and 54.6% for the three and nine months ended March 31, 2018, respectively.

On December 22, 2017 legislation, commonly referred to as the Tax Cuts and Jobs Act (the “Act”), was enacted. The Act included a one-time tax on accumulated unremitted earnings of our foreign subsidiaries (“Transition Tax”). SEC Staff Accounting Bulletin

29

No. 118 allowed the use of provisional amounts (reasonable estimates) if accounting for the income tax effects of the Act was not completed. Provisional amounts must be adjusted within a one-year measurement period from the enactment date of the Act. In the second quarter of fiscal year 2018, the Company recorded a discrete $236.9 million provisional Transition Tax charge. During the measurement period the Company gathered information and analyzed available guidance to more precisely compute the amount of the Transition Tax. In the second quarter of fiscal year 2019 the Company completed this work and recorded a discrete $22.1 million measurement period adjustment for the Transition Tax, which increased the Company’s effective tax rate for the nine months ended March 30, 2019 by 3.8%. As of the end of the second quarter of fiscal year 2019 accounting for the income tax effects of the Act were completed.

The Act reduced the federal statutory tax rate from 35% to 21%, effective January 1, 2018, which resulted in a fiscal year 2018 federal statutory tax rate of 28.1% for the Company (average of a 35% rate for the first half of fiscal year 2018 and a 21% rate for the second half of fiscal year 2018). The Company’s federal statutory tax rate for fiscal year 2019 is 21%. In the second quarter of fiscal year 2018 the Company recorded a $13.7 million discrete charge to remeasure deferred tax assets and liabilities as of the enactment date of the Act to reflect the federal statutory tax rate reductions.

The Act included Global Intangible Low-Taxed Income (“GILTI”) provisions, which first impact the Company in fiscal year 2019. The GILTI provisions effectively subject income earned by the Company’s foreign subsidiaries to current U.S. tax at a rate of 10.5%, less foreign tax credits. The Company has elected to treat tax generated by the GILTI provisions as a period expense.

The Company’s federal statutory tax rate for fiscal year 2019 is 21%. The Company’s effective tax rate for the three months ended March 30, 2019 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by tax generated by the GILTI provisions, a $4.1 million discrete charge for differences between our fiscal year 2018 tax returns and the tax provision originally recorded, and $5.7 million of discrete interest accruals for unrecognized tax benefits.

The Company’s effective tax rate for the nine months ended March 30, 2019 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by $21.0 million of discrete charges for the Transition Tax , tax generated by GILTI provisions, $15.1 million of discrete interest accruals for unrecognized tax benefits, and $4.8 million of discrete charges for differences between our fiscal year 2018 tax returns and the tax provision originally recorded.

The Company’s federal statutory tax rate for fiscal year 2018 was 28.1%. The Company’s effective tax rate for the three months ended March 31, 2018 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, and $4.6 million of discrete excess tax benefits generated by the settlement of share-based awards, partially offset by $5.1 million of discrete interest accruals for unrecognized tax benefits.

The Company’s effective tax rate for the nine months ended March 31, 2018 was higher than the statutory rate primarily due to a $236.9 million discrete provisional charge for the Transition Tax, a $13.7 million discrete charge to remeasure deferred taxes as of the enactment date of the Act, and $13.1 million of discrete interest accruals for unrecognized tax benefits, partially offset by earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates and $8.3 million of discrete excess tax benefits generated by the settlement of share-based awards.

BACKLOG

As of March 30, 2019 and June 30, 2018, our current quarter backlog was approximately $398.8 million and $441.1 million, respectively. In backlog, we include orders with customer request dates within the next three months. As is customary in the semiconductor industry, these orders may be canceled in most cases without penalty to customers. Accordingly, we believe that our backlog is not a reliable measure of future revenues. All backlog numbers have been adjusted for estimated future distribution ship and debit pricing adjustments.

30

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

Financial Condition

Cash flows were as follows:

	Nine Months Ended
	March 30, 2019			March 31, 2018
	(in thousands)
Net cash provided by (used in) operating activities	$	638,373		$	672,805
Net cash provided by (used in) investing activities	785,387			(708,819		)
Net cash provided by (used in) financing activities	(1,312,681		)	(580,514		)
Net increase (decrease) in cash and cash equivalents	$	111,079		$	(616,528	)

Operating activities

Cash provided by operating activities is net income adjusted for certain non-cash items and changes in certain assets and liabilities.

Cash provided by operating activities was $638.4 million in the nine months ended March 30, 2019, a decrease of $34.4 million compared with the nine months ended March 31, 2018. This decrease was due to changes in working capital and adjustments for non-cash items, partially offset by higher net income.

Investing activities

Investing cash flows consist primarily of net investment purchases and maturities, and capital expenditures.

Cash provided by investing activities was $785.4 million for the nine months ended March 30, 2019, compared with cash used in investing activities of $708.8 million for the nine months ended March 31, 2018, a change of $1.5 billion. The change was due to lower purchases of and higher proceeds from maturity of available-for-sale securities.

Financing activities

Financing cash flows consist primarily of debt issuance, repurchases of common stock, and payment of dividends to stockholders.

Net cash used in financing activities increased by approximately $732.2 million for the nine months ended March 30, 2019 compared to the nine months ended March 31, 2018. The increase was due to the repayment of the November 2018 Notes and repurchases of our common stock.

Liquidity and Capital Resources

As of March 30, 2019, our available funds consisted of $1.9 billion in cash, cash equivalents and short-term investments. We anticipate that the available funds and cash generated from operations will be sufficient to meet cash and working capital requirements, including the anticipated level of capital expenditures, common stock repurchases, debt repayments and dividend payments for at least the next twelve months.

In November 2018, the Company repaid $500.0 million of principal and related outstanding interest of the Company's 2.5% coupon notes.

In January 2019, the Company terminated its $350.0 million revolving credit facility with certain institutional lenders.

On October 30, 2018, we were authorized to repurchase up to $1.5 billion of the Company's common stock. During the three and nine months ended March 30, 2019, we repurchased an aggregate of $117.0 million and $437.0 million, respectively, of the Company's common stock.

During the three and nine months ended March 30, 2019, we paid cash dividends of $0.46 and $1.38 per common share totaling $125.6 million and $380.2 million, respectively.

31

Off-Balance-Sheet Arrangements

As of March 30, 2019, we did not have any material off-balance-sheet arrangements, as defined in Item 303(a)(4)(ii) of SEC Regulation S-K.

ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company’s market risk has not changed materially from the interest rate and foreign currency risks disclosed in Item 7A of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2018.

The impact of inflation and changing prices on the Company’s net revenues and on operating income during the three and nine months ended March 30, 2019 and March 31, 2018 was not material.

ITEM 4: CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer (“CEO”) and our chief financial officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”) as of March 30, 2019. Our management, including the CEO and the CFO, has concluded that the Company’s disclosure controls and procedures were effective as of March 30, 2019. The purpose of these controls and procedures is to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules, and that such information is accumulated and communicated to our management, including our CEO and our CFO, to allow timely decisions regarding required disclosures.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended March 30, 2019 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

Inherent Limitations on the Effectiveness of Internal Controls

A system of internal control over financial reporting is intended to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements in accordance with GAAP, and no control system, no matter how well designed and operated, can provide absolute assurance. The design of any control system is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of its inherent limitations, internal control over financial reporting may not prevent or detect financial statement errors and misstatements. Also, projection of any evaluation of effectiveness to future periods is subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

32

PART II. OTHER INFORMATION

ITEM 1: LEGAL PROCEEDINGS

The information set forth above under Part I, Item 1, Note 11 “Commitments and Contingencies” to the Condensed Consolidated Financial Statements is incorporated herein by reference.

ITEM 1A: RISK FACTORS

A description of risks associated with our business, financial condition and results of our operations is set forth in Item 1A - Risk Factors of our Annual Report on Form 10-K for the fiscal year ended June 30, 2018, which is incorporated herein by reference.

ITEM 2: UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On July 20, 2017, the Board of Directors of the Company authorized the repurchase of up to $1.0 billion of the Company's common stock. The stock repurchase authorization did not have an expiration date and the pace of repurchase activity depended on factors such as current stock price, levels of cash generation from operations, cash requirements, and other factors. The Company's prior repurchase authorization was cancelled and superseded by this repurchase authorization.

On October 30, 2018, the Board of Directors of the Company authorized the repurchase of up to $1.5 billion of the Company’s common stock. This stock repurchase authorization does not have an expiration date and the pace of repurchase activity will depend on factors such as current stock price, levels of cash generation from operations, cash requirements, and other factors. The Company’s prior repurchase authorization was cancelled and superseded by this new repurchase authorization.

The following table summarizes the activity related to stock repurchases for the three months ended March 30, 2019:

	Issuer Repurchases of Equity Securities
	(in thousands, except per share amounts)
	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs
Dec 30, 2018 - Jan 26, 2019	1,076	$	51.03	1,076	$	1,279,163
Jan 27, 2019 - Feb 23, 2019	769	55.05		769	1,236,842
Feb 24, 2019 - Mar 30, 2019	365	54.18		365	1,217,087
Total for the quarter	2,210	$	52.95	2,210	$	1,217,087

In the fiscal quarter ended March 30, 2019, the Company repurchased approximately 2.2 million shares of its common stock for approximately $117.0 million. As of March 30, 2019, the Company had remaining authorization of $1.2 billion for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company’s common stock and general market and business conditions.

ITEM 3: DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4: MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5: OTHER INFORMATION

None.

33

ITEM 6: EXHIBITS

(a) Exhibits

31.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act (1)
31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act (1)
32.1	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 (1)
32.2	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 (1)
EX-101.INS	XBRL INSTANCE DOCUMENT (1)
EX-101.SCH	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT (1)
EX-101.CAL	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT (1)
EX-101.DEF	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT (1)
EX-101.LAB	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT (1)
EX-101.PRE	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT (1)

(1) Filed or furnished herewith.

In accordance with Rule 406T of Regulation S-T, the XBRL-related information in Exhibit 101 to this Quarterly Report on Form 10-Q is deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act, is deemed not filed for purposes of Section 18 of the Exchange Act, and otherwise is not subject to liability under these sections.

34

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

May 1, 2019	MAXIM INTEGRATED PRODUCTS, INC.
	By:/s/ Bruce E. Kiddoo
	Bruce E. Kiddoo
	Senior Vice President, Chief Financial Officer and Chief Accounting Officer

35

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Tunç Doluca, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Maxim Integrated Products, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	May 1, 2019	/s/ Tunç Doluca
		Tunç Doluca
		President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Bruce E Kiddoo, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Maxim Integrated Products, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	May 1, 2019	/s/ Bruce E. Kiddoo
		Bruce E. Kiddoo
		Senior Vice President, Chief Financial Officer and Chief Accounting Officer

EX-32.1

Exhibit 32.1

CERTIFICATE OF CHIEF EXECUTIVE OFFICER

In connection with the periodic report of Maxim Integrated Products, Inc. (the "Company") on Form 10-Q for the period ended March 30, 2019 as filed with the Securities and Exchange Commission (the "Report"), I, Tunç Doluca, Chief Executive Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

1. the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

This Certification has not been, and shall not be deemed, "filed" with the Securities and Exchange Commission.

Date: May 1, 2019

By:	/s/ Tunç Doluca
	Tunç Doluca President and Chief Executive Officer

This certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended or the Securities Exchange Act of 1934, as amended.

EX-32.2

Exhibit 32.2

CERTIFICATE OF CHIEF FINANCIAL OFFICER

In connection with the periodic report of Maxim Integrated Products, Inc. (the "Company") on Form 10-Q for the period ended March 30, 2019 as filed with the Securities and Exchange Commission (the "Report"), I, Bruce E. Kiddoo, Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

1. the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

This Certification has not been, and shall not be deemed, "filed" with the Securities and Exchange Commission.

Date: May 1, 2019

By:	/s/ Bruce E. Kiddoo
	Bruce E. Kiddoo Senior Vice President, Chief Financial Officer and Chief Accounting Officer

This certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended or the Securities Exchange Act of 1934, as amended.

XML

Document and Entity Information Document - shares	3 Months Ended	9 Months Ended
	Mar. 30, 2019	Mar. 30, 2019	Apr. 18, 2019
DEI [Abstract]
Entity Registrant Name		MAXIM INTEGRATED PRODUCTS INC
Entity Central Index Key		0000743316
Trading Symbol	MXIM
Document Type		10-Q
Amendment Flag		false
Document Period End Date		Mar. 30, 2019
Document Fiscal Year Focus		2019
Document Fiscal Period Focus		Q3
Entity Emerging Growth Company	false
Entity Small Business	false
Current Fiscal Year End Date		--06-29
Entity Filer Category		Large Accelerated Filer
Entity Common Stock, Shares Outstanding			272,425,069

XML

Condensed Consolidated Balance Sheets - USD ($)	3 Months Ended
	Mar. 30, 2019	Jun. 30, 2018
Finite-Lived Intangible Assets, Gross	$ 617,825,000	$ 613,599,000
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	106,011,000
Current assets:
Cash and cash equivalents	1,654,563,000	1,543,484,000
Short-term Investments	243,864,000	1,082,915,000
Total cash, cash equivalents and short-term investments	1,898,427,000	2,626,399,000
Accounts receivable, net	381,152,000	280,072,000
Inventories	272,832,000	282,390,000
Other assets current	24,358,000	21,548,000
Total current assets	2,576,769,000	3,210,409,000
Property, plant and equipment, net	571,955,000	579,364,000
Intangible assets, net	61,036,000	78,246,000
Goodwill	532,251,000	532,251,000
Other assets noncurrent	61,843,000	51,291,000
TOTAL ASSETS	3,803,854,000	4,451,561,000
Current liabilities:
Accounts payable	86,798,000	92,572,000
Price adjustment and other revenue reserves	106,011,000	0
Income taxes payable	44,179,000	17,961,000
Accrued salary and related expenses	128,365,000	151,682,000
Accrued expenses	33,644,000	35,774,000
Short-term Debt	0	499,406,000
Total current liabilities	398,997,000	797,395,000
Long term debt	992,225,000	991,147,000
Income taxes payable	688,780,000	661,336,000
Other liabilities	61,105,000	70,743,000
Total liabilities	2,141,107,000	2,520,621,000
Commitments and contingencies (Note 11)
Stockholders' equity:
Common stock and capital in excess of par value	279,000	279,000
Retained earnings	1,672,938,000	1,945,646,000
Accumulated other comprehensive loss	(10,470,000)	(14,985,000)
Total stockholders' equity	1,662,747,000	1,930,940,000
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY	3,803,854,000	4,451,561,000
Intellectual Property [Member]
Finite-Lived Intangible Assets, Gross	$ 488,846,000	$ 485,465,000

XML

Condensed Consolidated Balance Sheets Parenthetical - USD ($) $ in Thousands	Mar. 30, 2019	Jun. 30, 2018
Statement of Financial Position [Abstract]
Allowance for Doubtful Accounts Receivable, Current	$ 608	$ 140,296

XML

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Interest Expense	$ 9,300	$ 12,400	$ 33,900	$ 37,600
Interest Expense, Debt	8,900	12,400	32,500	37,100
Allocated Share-based Compensation Expense	22,820	20,605	64,973	58,932
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	1,946	2,053	6,214	6,830
Allocated Share-based Compensation Expense, Net of Tax	20,874	18,552	58,759	52,102
Revenue from Contract with Customer, Excluding Assessed Tax	542,383	648,599	1,757,784	1,846,913
Net revenues	542,383	648,599	1,757,784	1,846,913
Cost of goods sold	201,552	224,653	613,669	639,460
Gross margin	340,831	423,946	1,144,115	1,207,453
Operating expenses:
Research and development	107,075	114,390	330,086	338,886
Selling, general and administrative	74,116	81,304	233,487	240,308
Intangible asset amortization	756	876	2,285	3,623
Impairment of long-lived assets	0	0	753	892
Severance and Restructuring Charges	1,744	2,272	3,917	14,227
Other operating expenses (income), net	0	266	60	(1,535)
Total operating expenses	183,691	199,108	570,588	596,401
Operating income	157,140	224,838	573,527	611,052
Interest and other income (expense), net	3,318	(2,534)	3,244	(9,868)
Income before provision for income taxes	160,458	222,304	576,771	601,184
Income tax provision (benefit)	29,845	28,677	116,843	328,038
Net income	$ 130,613	$ 193,627	$ 459,928	$ 273,146
Earnings per share:
Basic	$ 0.48	$ 0.69	$ 1.67	$ 0.97
Diluted	$ 0.47	$ 0.68	$ 1.64	$ 0.95
Shares used in the calculation of earnings per share:
Basic	273,221	280,850	275,831	281,525
Diluted	276,610	285,881	279,680	286,221
Employee Stock Option [Member]
Allocated Share-based Compensation Expense	$ 77	$ 99	$ 233	$ 1,339
Restricted Stock Units (RSUs) [Member]
Allocated Share-based Compensation Expense	19,534	17,946
ESP Plan [Member]
Allocated Share-based Compensation Expense	3,209	2,560	7,760	6,594
Restricted Stock [Member]
Allocated Share-based Compensation Expense			56,980	50,999
Cost of Sales [Member]
Allocated Share-based Compensation Expense	2,613	2,575	7,281	7,461
Cost of Sales [Member] | Employee Stock Option [Member]
Allocated Share-based Compensation Expense	8	35	28	196
Cost of Sales [Member] | Restricted Stock Units (RSUs) [Member]
Allocated Share-based Compensation Expense	1,951	2,003	5,597	5,783
Cost of Sales [Member] | ESP Plan [Member]
Allocated Share-based Compensation Expense	654	537	1,656	1,482
Research and Development Expense [Member]
Allocated Share-based Compensation Expense	11,062	10,077	30,758	28,061
Research and Development Expense [Member] | Employee Stock Option [Member]
Allocated Share-based Compensation Expense	5	13	27	507
Research and Development Expense [Member] | Restricted Stock Units (RSUs) [Member]
Allocated Share-based Compensation Expense	9,399	8,725	26,783	24,212
Research and Development Expense [Member] | ESP Plan [Member]
Allocated Share-based Compensation Expense	$ 1,658	$ 1,339	3,948	3,342
Selling, General and Administrative Expenses [Member]
Allocated Share-based Compensation Expense			26,934	23,410
Selling, General and Administrative Expenses [Member] | Employee Stock Option [Member]
Allocated Share-based Compensation Expense			178	636
Selling, General and Administrative Expenses [Member] | Restricted Stock Units (RSUs) [Member]
Allocated Share-based Compensation Expense			24,600	21,004
Selling, General and Administrative Expenses [Member] | ESP Plan [Member]
Allocated Share-based Compensation Expense			$ 2,156	$ 1,770

XML

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Statements of Income and Comprehensive Income [Abstract]
Net income	$ 130,613	$ 193,627	$ 459,928	$ 273,146
Change in net unrealized gains and losses on available-for-sale securities, net of tax benefit (expense) of $97, $274, ($131), and $274, respectively	1,139	(1,213)	3,116	(3,433)
Change in net unrealized gains and losses on cash flow hedges, net of tax benefit (expense) of $69, $6, $(241), and $(45), respectively	(351)	(217)	1,167	133
Change in net unrealized gains and losses on post-retirement benefits, net of tax benefit (expense) of $(23), $(4), $(60), and $(168), respectively	78	18	232	(14)
Other comprehensive income (loss), net	866	(1,412)	4,515	(3,314)
Total comprehensive income	131,479	192,215	464,443	269,832
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	97	274	(131)	274
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax	69	6	(241)	(45)
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax	$ (23)	$ (4)	$ (60)	$ (168)

XML

Condensed Consolidated Statement of Shareholders' Equity Statement - USD ($) shares in Thousands		Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]
Common Stock, Shares, Outstanding		282,912
Stockholders' Equity, Other		$ 1,985,698,000	$ 283,000		$ 1,997,207,000	$ (11,792,000)
Stockholders' Equity, Other		$ 1,930,940,000			1,945,646,000	(14,985,000)
Common Stock, Shares, Outstanding			281,438
Common Stock, Shares, Outstanding		278,664
Stockholders' Equity, Other		$ 1,755,414,000	$ 279,000		1,766,471,000	(11,336,000)
Stockholders' Equity, Other		1,662,747,000	$ 279,000		1,672,938,000	(10,470,000)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		459,928,000			459,928,000
Other Comprehensive Income (Loss), Net of Tax		4,515,000
Shares of common stock repurchased			(8,032)
Value of common stock repurchased		(437,047,000)	$ 0	$ 82,155,000	354,892,000	0
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures			980
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures		(23,026,000)	$ 0	(23,026,000)	0	0
Stock Issued During Period, Shares, Other			699
Stock Issued During Period, Value, Stock Options Exercised		18,986,000	$ 0	18,986,000	0	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition		65,035,000	$ 0	65,035,000	0	0
Modification Of Liability Instruments To Equity	[1]			3,471,000
Stock Issued During Period, Shares, Employee Stock Purchase Plans			384
Stock Issued During Period, Value, Employee Stock Ownership Plan			$ 0
Stock Issued During Period, Value, Employee Stock Purchase Plan		17,689,000		17,689,000	0	0
Dividends		1.38
Dividends, Common Stock, Cash		$ (380,231,000)	$ 0	$ 0	(380,231,000)	$ 0
Common Stock, Shares, Outstanding			274,326
Common Stock, Shares, Outstanding		272,695
Cumulative Effect of New Accounting Principle in Period of Adoption		$ 2,487,000			$ 2,487,000

[1] (1) In December 2018, $3.5 million was reclassified from accrued salaries to additional paid-in capital due to a settlement agreement relating to the expiration of stock options.

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income	$ 459,928	$ 273,146
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	64,973	58,932
Depreciation and amortization	85,176	109,768
Deferred taxes	(12,161)	6,257
Gain (Loss) on Disposition of Property Plant Equipment	3,324	572
Impairment of investments in privately-held companies	265	850
Other adjustments	0	42
Changes in assets and liabilities:
Accounts receivable	5,475	(60,194)
Inventories	9,620	(23,326)
Other current assets	(3,026)	31,703
Accounts payable	(10,971)	3,429
Income taxes payable	53,662	280,664
Deferred income on shipments to distributors	0	(14,974)
Accrued salary and related expenses	(19,845)	1,826
All other accrued liabilities	1,953	4,110
Net cash provided by (used in) operating activities	638,373	672,805
Cash flows from investing activities:
Purchases of property, plant and equipment	(52,170)	(53,664)
Proceeds from sale of property, plant, and equipment	34	5,761
Proceeds from sale of available-for-sale securities	30,192	100,004
Proceeds from maturity of available-for-sale securities	1,027,083	422,500
Payment in connection with business acquisition, net of cash acquired	(2,949)	(57,773)
Purchases of available-for-sale securities	(214,587)	(1,122,291)
Purchases of privately-held companies' securities	(1,676)	(3,356)
Payments for (Proceeds from) Other Investing Activities	(540)	0
Net cash provided by (used in) investing activities	785,387	(708,819)
Cash flows from financing activities:
Repayment of debt	(500,000)	0
Contingent consideration paid	(9,052)	0
Payments of Stock Issuance Costs	(23,026)	(21,162)
Proceeds from stock options exercised	18,986	26,383
Issuance of common stock under employee stock purchase program	17,689	14,975
Repurchase of common stock	(437,047)	(279,944)
Payments of Dividends	(380,231)	(320,766)
Net cash provided by (used in) financing activities	(1,312,681)	(580,514)
Net increase (decrease) in cash and cash equivalents	111,079	(616,528)
Cash and cash equivalents:
Beginning of period	1,543,484	2,246,121
End of period	1,654,563	1,629,593
Supplemental disclosures of cash flow information:
Cash paid (refunded), net during the period for income taxes	74,385	17,281
Cash paid for interest	31,751	31,750
Noncash investing and financing activities:
Accounts payable related to property, plant, and equipment purchases	$ 15,252	$ 6,798

XML

Basis of Presentation

9 Months Ended

Mar. 30, 2019

Basis of Presentation [Abstract]

Basis of Presentation [Text Block]

BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements of Maxim Integrated Products, Inc. and all of its majority-owned subsidiaries (collectively, the “Company” or “Maxim Integrated”) included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with generally accepted accounting principles of the United States of America (“GAAP”) have been condensed or omitted pursuant to applicable rules and regulations. In the opinion of management, all adjustments of a normal recurring nature which were considered necessary for fair statement have been included. The year-end condensed consolidated balance sheet data were derived from audited consolidated financial statements but do not include all disclosures required by GAAP. The results of operations for the nine months ended March 30, 2019 are not necessarily indicative of the results to be expected for the entire year. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2018.

The Company has a 52-to-53-week fiscal year that ends on the last Saturday in June. Accordingly, every fifth or sixth fiscal year will be a 53-week fiscal year. Fiscal year 2018 was a 53-week fiscal year and fiscal year 2019 is a 52-week fiscal year. The second quarter of fiscal year 2018 was a 14-week quarter and the second quarter of fiscal year 2019 was a 13-week quarter.

XML

Recently Issued Accounting Pronouncements

9 Months Ended

Mar. 30, 2019

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

Recently Issued Accounting Pronouncements [Text Block]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Recently Issued Accounting Pronouncements

(i) New Accounting Updates Recently Adopted

In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09, Revenue from Contracts with Customers (Topic 606). This standard provides a single set of guidelines for revenue recognition to be used across all industries. Under the new standard, revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires reporting companies to disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers.

On July 1, 2018, the Company adopted Topic 606 and related amendments (ASU 2015-14, Deferral of the Effective Date; ASU 2016-08, Principal versus Agent Considerations; ASU 2016-10, Identifying Performance Obligations and Licensing, ASU 2016-12, Narrow-Scope Improvements and Practical Expedients and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers) using the modified retrospective method applied to all contracts that are not completed at the date of initial application (i.e., July 1, 2018). Results for reporting periods beginning after July 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with historic accounting standards under Topic 605.

There was no impact on the opening retained earnings as of July 1, 2018 due to the adoption of Topic 606. However, in conjunction with the adoption of the new standard, the Company recorded a reclassification of accrued revenue reserves for price adjustments and other revenue reserves from accounts receivable, net to price adjustment and other revenue reserves within current liabilities.

The cumulative effect of the changes to the condensed consolidated balance sheet from the adoption of Topic 606 was as follows (in thousands):

	As of June 30, 2018		Effect of Adoption of Topic 606		As of July 1, 2018
Accounts receivable, net	$	280,072	$	141,652	$	421,724
Price adjustment and other revenue reserves	—		141,652		141,652

Balance Sheet Reclassification

Under Topic 605, the gross amount of accrued revenue reserves for price adjustments and other revenue reserves of $141.7 million was included within accounts receivable, net as of June 30, 2018. Subsequent to the adoption of Topic 606, such balances are presented on a gross basis as accrued price adjustments and other revenue reserves of $141.7 million, which is presented in the price adjustment and other revenue reserves balance sheet caption.

The adoption of Topic 606 has no impact on the total cash flows from operating, investing, or financing activities on the Condensed Consolidated Statements of Cash Flows.

The following table summarizes the impacts of adopting Topic 606 on the Company’s Condensed Consolidated Balance Sheet as of March 30, 2019 (in thousands):

	As Reported		If Reported Under Topic 605		Effect of Adoption of Topic 606
Accounts receivable, net	$	381,152	$	275,141	$	106,011
Price adjustment and other revenue reserves	106,011		—		106,011

Practical Expedients and Elections

• The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which the Company recognizes revenue at the amount to which it has the right to invoice for services performed.

• The Company has elected to account for shipping and handling costs as fulfillment costs after the customer obtains control of the goods.

• The Company has elected to exclude sales, use, value added, and some excise taxes, if applicable, from the measurement of the transaction price. 

Updated Revenue Recognition Policy

The Company recognizes revenue for sales to direct customers and distribution customers ("distributors") when a customer obtains control of promised goods or services in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. The transaction price is calculated as selling price net of variable considerations, such as distributor price adjustments. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it is expected to be entitled. The transaction price does not include amounts collected on behalf of another party, such as sales taxes or value added tax. The Company elected the practical expedient to not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company estimates returns for sales to direct customers and distributors based on historical return rates applied against current period gross revenue. Specific customer returns and allowances are considered within this estimate.

Accounts receivable from direct customers and distributors are recognized and inventory is relieved upon shipment as title to inventories generally transfers upon shipment, at which point the Company has a legally enforceable right to collection under normal terms. Accounts receivable related to consigned inventory is recognized when the customer takes title to such inventory from its consigned location, at which point inventory is relieved, title transfers, and the Company has a legally enforceable right to collection under the terms of the agreement with the related customers. Customers are generally required to pay for products and services within the Company’s standard terms, which is net 30 days from the date of invoice. The Company does not have any significant financing components greater than one year.

The Company estimates potential future returns and sales allowances related to current period product revenue. Management analyzes historical returns, changes in customer demand and acceptance of products when evaluating the adequacy of returns and sales allowances. Estimates made may differ from actual returns and sales allowances. These differences may materially impact reported revenue and amounts ultimately collected on accounts receivable. Historically, such differences have not been material.

Distributor price adjustments are estimated based on the Company's historical experience rates and also considering economic conditions and contractual terms. To date, actual distributor claims activity has been materially consistent with the estimates that the Company has made based on its historical rates.

The Company's revenue arrangements do not contain significant financing components. Revenue is recognized over a period of time when it is assessed that performance obligations are satisfied over a period rather than at a point in time. When any of the following criteria is fulfilled, revenue is recognized over a period of time:

(a) The customer simultaneously receives and consumes the benefits provided by the performance completed.

(b) Performance creates or enhances an asset (for example, work in process) that the customer controls as the asset is created or enhanced.

(c) Performance does not create an asset with an alternative use, and has an enforceable right to payment for performance completed to date.

In January 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, with further classifications made recently with the issuance of ASU 2018-03 and ASU 2018-04, which provides guidance for the recognition, measurement, presentation, and disclosure of financial assets and liabilities. The application of this ASU was made by the means of a cumulative-effect adjustment to the balance sheet for the equity securities that qualify for the practical expedient to estimate fair value using the net asset value per share. The amendments related to equity securities without readily determinable fair values (including disclosure requirements) is being applied prospectively to equity investments that exist as of the date of adoption. The Company adopted ASU 2016-01 in the first quarter of fiscal year 2019. As a result of this adoption, the Company recognized an increase of $2.5 million, net of tax, in retained earnings at the beginning of fiscal year 2019.

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory. ASU 2016-16 requires that entities recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs instead of when the asset is sold. The Company adopted ASU 2016-16 in the first quarter of fiscal year 2019. The adoption of this guidance did not have an impact on the Company's consolidated financial statements.

In March 2017, the FASB issued ASU 2017-07, Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, which requires employers that offer or maintain defined benefit plans to disaggregate the service component from the other components of net benefit cost and provides guidance on presentation of the service component and the other components of net benefit cost in the statement of operations. The application of ASU 2017-07 requires retrospective basis for all periods presented. The Company adopted ASU 2017-07 in the first quarter of fiscal year 2019. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.

In May 2017, the FASB issued ASU 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. The amendments in this standard provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. Unless the changes in terms or conditions meet all three criteria outlined in the guidance, modification accounting should be applied. The three criteria relate to changes in the terms and conditions that affect the fair value, vesting conditions, or classification of a share-based payment award. The guidance is required to be applied prospectively to an award modified on or after the adoption date. The Company adopted ASU 2017-09 in the first quarter of fiscal year 2019. The adoption of this guidance did not have an impact on the Company's consolidated financial statements.

In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. This standard provides guidance about the reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act. The Company adopted ASU 2018-02 in the first quarter of fiscal year 2019. There was no material change to the Company's consolidated financial statements as a result of this adoption.

In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Non-employee Share-Based Payment Accounting. This ASU largely aligns the accounting for share-based payment awards to employees and non-employees. Under the new guidance, both sets of awards, for employees and non-employees, will essentially follow the same model, with small discrepancies related to the term assumption when valuing non-employee awards. The Company adopted ASU 2018-07 in the first quarter of fiscal year 2019. The adoption of this guidance did not have an impact on the Company's consolidated financial statements.

SEC Disclosure Update and Simplification. In August 2018, the SEC adopted a final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, which amends certain disclosure requirements that were redundant and outdated. The rule also requires registrants to include in their interim financial statements a reconciliation of changes in stockholders' equity in the notes or as a separate statement. The final rule was effective on November 5, 2018. The Company has adopted the final rule as of December 29, 2018, and has included a reconciliation of the changes in stockholders' equity in this Form 10-Q.

(ii) Recent Accounting Updates Not Yet Effective

In February 2016, the FASB issued ASU 2016-02, Leases and subsequent amendments to the initial update: ASU 2017-13, ASU 2018-01, ASU 2018-11, ASU 2018-20 and ASU 2019-01 (collectively, Topic 842), which supersede the lease accounting requirements in Topic 840. Topic 842 requires a dual approach for lessee accounting under which a lessee would account for leases as finance leases or operating leases. Both finance leases and operating leases will result in the lessee recognizing a right-of-use asset and a corresponding lease liability. For finance leases, the lessee would recognize interest expense and amortization of the right-of-use asset, and for operating leases, the lessee would recognize a straight-line total lease expense. The guidance also requires qualitative and specific quantitative disclosures to supplement the amounts recorded in the financial statements so that users can understand more about the nature of an entity’s leasing activities, including significant judgments and changes in judgments. This guidance is effective beginning in the first quarter of fiscal year 2020 on a modified retrospective approach. The Company is currently evaluating the potential impact of this standard on its consolidated financial statements and expects that there will be a material increase in assets and liabilities on the Consolidated Balance Sheets at adoption due to the recognition of right-of-use assets and related lease liabilities. Upon adoption, the Company expects that its financial statement disclosures will be expanded to present additional details of its leasing arrangements.

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which improves disclosures by removing, modifying and adding disclosure requirements related to fair value measurements. The update highlights adjustments in disclosures for changes in the fair value of Level 1, Level 2, and Level 3 instruments. This guidance is effective beginning in the first quarter of fiscal year 2021, with early adoption permitted. The Company does not believe that this update will have a material impact on its consolidated financial statements.

XML

Balance Sheet Components

9 Months Ended

Mar. 30, 2019

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Components [Text Block]

BALANCE SHEET COMPONENTS

Inventories consist of:

	March 30, 2019		June 30, 2018
Inventories:	(in thousands)
Raw materials	$	18,799	$	16,251
Work-in-process	172,020		173,859
Finished goods	82,013		92,280
	$	272,832	$	282,390

Property, plant and equipment, net consists of:

	March 30, 2019			June 30, 2018
Property, plant and equipment, net:	(in thousands)
Land	$	17,731		$	17,731
Buildings and building improvements	258,642			254,733
Machinery, equipment and software	1,358,892			1,309,487
	1,635,265			1,581,951
Less: accumulated depreciation	(1,063,310		)	(1,002,587		)
	$	571,955		$	579,364

Accrued salary and related expenses consist of:

	March 30, 2019		June 30, 2018
Accrued salary and related expenses:	(in thousands)
Accrued vacation	$	28,831	$	30,695
Accrued bonus	56,187		92,288
Accrued salaries	13,711		8,210
ESPP withholding	15,634		5,158
Accrued fringe benefits	8,075		4,752
Other	5,927		10,579
	$	128,365	$	151,682

XML

Fair Value Measurements

9 Months Ended

Mar. 30, 2019

Fair Value Disclosures [Abstract]

Fair Value Measurements [Text Block]

FAIR VALUE MEASUREMENTS

The FASB established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Three levels of inputs that may be used to measure fair value are as follows:

Level 1 - Quoted (unadjusted) prices in active markets for identical assets or liabilities.

The Company’s Level 1 assets consist of money market funds.

Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.

The Company’s Level 2 assets and liabilities consist of U.S. Treasury securities, agency securities, corporate debt securities, certificates of deposit, commercial paper and foreign currency forward contracts that are valued using quoted market prices or are determined using a yield curve model based on current market rates.

Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

The Company's Level 3 assets and liabilities consist of acquisition related contingent consideration liabilities.

Assets and liabilities measured at fair value on a recurring basis were as follows:

	As of March 30, 2019								As of June 30, 2018
	Fair Value  Measurements Using						Total Balance		Fair Value  Measurements Using						Total Balance
	Level 1		Level 2		Level 3				Level 1		Level 2		Level 3
	(in thousands)
Assets
Cash and cash equivalents
Agency securities	$	—	$	—	$	—	$	—	$	—	$	13,946	$	—	$	13,946
Certificates of deposit	—		—		—		—		—		6,000		—		6,000
Commercial paper	—		—		—		—		—		45,063		—		45,063
Corporate debt securities	—		—		—		—		—		3,819		—		3,819
Money market funds	195,805		—		—		195,805		98,467		—		—		98,467
U.S. Treasury securities	—		—		—		—		—		30,988		—		30,988
Short term investments
Certificates of deposit	—		5,000		—		5,000		—		52,428		—		52,428
Commercial paper	—		2,999		—		2,999		—		64,354		—		64,354
Corporate debt securities	—		185,994		—		185,994		—		367,765		—		367,765
U.S. Treasury securities	—		49,871		—		49,871		—		598,368		—		598,368
Other current assets
Foreign currency forward contracts	—		230		—		230		—		235		—		235
Total assets	$	195,805	$	244,094	$	—	$	439,899	$	98,467	$	1,182,966	$	—	$	1,281,433
Liabilities
Accrued expenses
Foreign currency forward contracts	$	—	$	496	$	—	$	496	$	—	$	1,845	$	—	$	1,845
Contingent consideration	—		—		9,052		9,052		—		—		8,000		8,000
Other liabilities
Contingent consideration	—		—		—		—		—		—		8,000		8,000
Total Liabilities	$	—	$	496	$	9,052	$	9,548	$	—	$	1,845	$	16,000	$	17,845

During the nine months ended March 30, 2019 and the year ended June 30, 2018, there were no transfers in or out of Level 3 from other levels in the fair value hierarchy.

There were no assets or liabilities measured at fair value on a non-recurring basis as of March 30, 2019 and June 30, 2018 other than impairments of long-lived assets. The Company uses various inputs to evaluate investments in privately held companies, including valuations of recent financing events as well as other relevant information regarding the performance of the issuer. There were no material impairments of long-lived assets in any of the periods presented.

XML

Financial Instruments

9 Months Ended

Mar. 30, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Financial Instruments [Text Block]

FINANCIAL INSTRUMENTS

Short-term investments

Fair values were as follows:

	March 30, 2019									June 30, 2018
	Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Estimated Fair Value		Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Estimated Fair Value
	(in thousands)
Available-for-sale investments
Certificates of deposit	$	5,000	$	—	$	—		$	5,000	$	52,429	$	—	$	(1	)	$	52,428
Commercial paper	2,999		—		—			2,999		64,354		—		—			64,354
Corporate debt securities	186,446		21		(473		)	185,994		369,734		39		(2,008		)	367,765
U.S. Treasury securities	49,973		—		(102		)	49,871		600,068		10		(1,710		)	598,368
Total available-for-sale investments	$	244,418	$	21	$	(575	)	$	243,864	$	1,086,585	$	49	$	(3,719	)	$	1,082,915

In the three and nine months ended March 30, 2019 and June 30, 2018, the Company did not recognize any impairment charges on short-term investments. All available-for-sale investments have maturity dates between April 1, 2019 and March 12, 2021.

The Company invests in various financial instruments including U.S. Treasury securities, corporate debt securities, commercial paper, and certificates of deposit which include instruments issued or managed by industrial, financial, and utility institutions and U.S. Treasury securities which include U.S. government Treasury bills and Treasury notes.

Derivative instruments and hedging activities

The Company incurs expenditures denominated in non-U.S. currencies, primarily the Philippine Peso and the Thai Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and the European Euro, Indian Rupee, Japanese Yen, Taiwan New Dollar, South Korean Won, Chinese Yuan and Canadian Dollar, for sales offices and research and development activities undertaken outside of the U.S.

The Company has established a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effects of certain foreign currency exposures. The Company does not use these foreign currency forward contracts for trading purposes.

Derivatives designated as cash flow hedging instruments

The Company designates certain forward contracts as hedging instruments pursuant to Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging (“ASC 815”). As of March 30, 2019 and June 30, 2018, the notional amounts of the forward contracts the Company held to purchase international currencies were $44.4 million and $49.7 million, respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $0 and $1.2 million, respectively.

Derivatives not designated as hedging instruments

As of March 30, 2019 and June 30, 2018, the notional amounts of the forward contracts the Company held to purchase international currencies were $19.9 million and $21.1 million, respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $21.9 million and $21.3 million, respectively. The Company's foreign currency forward contract gains or losses included in the Condensed Consolidated Statements of Income were not material for the three and nine months ended March 30, 2019 and March 31, 2018.

Effect of hedge accounting on the Condensed Consolidated Statements of Income

The following tables summarize the gains (losses) from hedging activities recognized in the Company's Condensed Consolidated Statements of Income:

	Three Months Ended							Nine Months Ended
	March 30, 2019							March 30, 2019
	Net Revenue		Cost of Goods Sold		Operating Expenses				Net Revenue		Cost of Goods Sold			Operating Expenses
	(in thousands)
Income and expenses line items in which the effects of cash flow hedges are recorded	$	542,383	$	201,552	$	183,691			$	1,757,784	$	613,669		$	570,588
Gain (loss) on cash flow hedges:
Foreign exchange contracts:
Gain (loss) reclassified from accumulated other comprehensive income into income	$	6	$	261	$	(79	)		$	50	$	(335	)	$	(1,906	)

	Three Months Ended							Nine Months Ended
	March 31, 2018							March 31, 2018
	Net Revenue			Cost of Goods Sold		Operating Expenses			Net Revenue			Cost of Goods Sold		Operating Expenses
	(in thousands)
Income and expenses line items in which the effects of cash flow hedges are recorded	$	648,599		$	224,653	$	199,108		$	1,846,913		$	639,460	$	596,401
Gain (loss) on cash flow hedges:
Foreign exchange contracts:
Gain (loss) reclassified from accumulated other comprehensive income into income	$	(11	)	$	165	$	356		$	(64	)	$	116	$	1,781

Outstanding debt obligations

The following table summarizes the Company’s outstanding debt obligations:

	March 30, 2019			June 30, 2018
	(in thousands)
3.45% fixed rate notes due June 2027	$	500,000		$	500,000
2.5% fixed rate notes due November 2018	—			500,000
3.375% fixed rate notes due March 2023	500,000			500,000
Total outstanding debt	1,000,000			1,500,000
Less: Current portion (included in "Current portion of debt")	—			(499,406		)
Less: Reduction for unamortized discount and debt issuance costs	(7,775		)	(9,447		)
Total long-term debt	$	992,225		$	991,147

On June 15, 2017, the Company completed a public offering of $500 million aggregate principal amount of the Company's 3.45% senior unsecured and unsubordinated notes due in June 2027 (“2027 Notes”), with an effective interest rate of 3.5%. Interest on the 2027 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, commencing on December 15, 2017. The net proceeds of this offering were approximately $495.2 million, after issuing at a discount and deducting paid expenses.

On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% coupon senior unsecured and unsubordinated notes due in November 2018 (“2018 Notes”), with an effective interest rate of 2.6%. Interest on the 2018 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing on May 15, 2014. The net proceeds of this offering were approximately $494.5 million, after issuing at a discount and deducting paid expenses. In November of 2018, the Company repaid the entire $500 million in principal and any outstanding interest, related to these outstanding notes.

On March 18, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 3.375% senior unsecured and unsubordinated notes due in March 2023 (“2023 Notes”), with an effective interest rate of 3.5%. Interest on the 2023 Notes is payable semi-annually in arrears on March 15 and September 15 of each year. The net proceeds of this offering were approximately $490.0 million, after issuing at a discount and deducting paid expenses.

The debt indentures that govern the 2027 Notes and the 2023 Notes include covenants that limit the Company's ability to grant liens on its facilities and to enter into sale and leaseback transactions, which could limit the Company's ability to secure additional debt funding in the future. In circumstances involving a change of control of the Company followed by a downgrade of the rating of the 2027 Notes or the 2023 Notes, the Company would be required to make an offer to repurchase the affected notes at a purchase price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest.

The Company accounts for all the notes above based on their amortized cost. The discount and expenses are being amortized to Interest and other income (expense), net in the Condensed Consolidated Statements of Income over the life of the notes. The interest expense is recorded in Interest and other income (expense), net in the Condensed Consolidated Statements of Income. Amortized discount and expenses, as well as interest expense associated with the notes, were $8.9 million and $12.4 million during the three months ended March 30, 2019 and March 31, 2018, respectively. Amortized discount and expenses, as well as interest expense associated with the notes, were $32.5 million and $37.1 million during the nine months ended March 30, 2019 and March 31, 2018, respectively.

The estimated fair value of the Company’s outstanding debt obligations was approximately $985 million as of March 30, 2019. The estimated fair value of the debt is based primarily on observable market inputs and is a Level 2 measurement.

The Company recorded interest expense of $9.3 million and $12.4 million during the three months ended March 30, 2019, and March 31, 2018, respectively. The Company recorded interest expense of $33.9 million and $37.6 million during the nine months ended March 30, 2019 and March 31, 2018, respectively.

Other Financial Instruments

For the balance of the Company’s financial instruments, cash equivalents, accounts receivable, accounts payable and other accrued liabilities, the carrying amounts approximate fair value due to their short maturities.

XML

Stock-Based Compensation

9 Months Ended

Mar. 30, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-Based Compensation [Text Block]

STOCK-BASED COMPENSATION

At March 30, 2019, the Company had one stock incentive plan, the Company's 1996 Stock Incentive Plan (the “1996 Plan”) and one employee stock purchase plan, the 2008 Employee Stock Purchase Plan (the “2008 ESPP”). The 1996 Plan was adopted by the Board of Directors to provide the grant of incentive stock options, non-statutory stock options, restricted stock units (“RSUs”), and market stock units (“MSUs”) to employees, directors, and consultants.

Pursuant to the 1996 Plan, the exercise price for incentive stock options and non-statutory stock options is determined to be the fair market value of the underlying shares on the date of grant. Options typically vest ratably over a four-year period measured from the date of grant. Options generally expire no later than seven years after the date of grant, subject to earlier termination upon an optionee's cessation of employment or service.

RSUs granted to employees typically vest ratably over a four-year period and are converted into shares of the Company's common stock upon vesting, subject to the employee's continued service to the Company over that period. RSUs granted after August 2017 will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements.

MSUs granted to employees typically vest over a four-year cliff period and are converted into shares of the Company's common stock upon vesting, subject to the employee's continued service to the Company over that period. The number of shares that are released at the end of the performance period can range from zero to a maximum cap depending on the Company's performance. MSUs granted after August 2017 will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements.

The following tables show total stock-based compensation expense by type of award, and the resulting tax effect, included in the Condensed Consolidated Statements of Income for the three and nine months ended March 30, 2019 and March 31, 2018, respectively:

	Three Months Ended
	March 30, 2019								March 31, 2018
	Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total		Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total
	(in thousands)
Cost of goods sold	$	8	$	1,951	$	654	$	2,613	$	35	$	2,003	$	537	$	2,575
Research and development	5		9,399		1,658		11,062		13		8,725		1,339		10,077
Selling, general and administrative	64		8,184		897		9,145		51		7,218		684		7,953
Pre-tax stock-based compensation expense	$	77	$	19,534	$	3,209	$	22,820	$	99	$	17,946	$	2,560	$	20,605
Less: income tax effect							1,946								2,053
Net stock-based compensation expense							$	20,874							$	18,552

	Nine Months Ended
	March 30, 2019								March 31, 2018
	Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total		Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total
	(in thousands)
Cost of goods sold	$	28	$	5,597	$	1,656	$	7,281	$	196	$	5,783	$	1,482	$	7,461
Research and development	27		26,783		3,948		30,758		507		24,212		3,342		28,061
Selling, general and administrative	178		24,600		2,156		26,934		636		21,004		1,770		23,410
Pre-tax stock-based compensation expense	$	233	$	56,980	$	7,760	$	64,973	$	1,339	$	50,999	$	6,594	$	58,932
Less: income tax effect							6,214								6,830
Net stock-based compensation expense							$	58,759							$	52,102

The expenses included in the Condensed Consolidated Statements of Income for RSUs include expenses related to MSUs of $3.0 million and $2.2 million for the three months ended March 30, 2019 and March 31, 2018, respectively, and $8.3 million and $5.8 million for the nine months ended March 30, 2019 and March 31, 2018, respectively.

Stock Options

The fair value of options granted to employees under the 1996 Plan is estimated on the date of grant using the Black-Scholes option valuation model.

There were no stock options granted in the three and nine months ended March 30, 2019 and March 31, 2018.

The following table summarizes outstanding, exercisable and vested and expected to vest stock options as of March 30, 2019 and related activity for the nine months ended March 30, 2019:

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value(1)
Balance at June 30, 2018	1,688,253		$	27.72
Options Granted	—		—
Options Exercised	(699,416	)	27.13
Options Cancelled	(3,439	)	28.08
Balance at March 30, 2019	985,398		$	28.14	1.3	$	25,692,173
Exercisable, March 30, 2019	985,398		$	28.14	1.3	$	25,692,173
Vested and expected to vest, March 30, 2019	985,398		$	28.14	1.3	$	25,692,173

(1) Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of March 30, 2019.

As of March 30, 2019, there was no unrecognized stock compensation from unvested stock options.

Restricted Stock Units and Other Awards

The fair value of RSUs and other awards under the Company’s 1996 Plan is estimated using the value of the Company’s common stock on the date of grant, reduced by the present value of dividends expected to be paid on the Company’s common stock prior to vesting. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis.

The weighted-average fair value of RSUs and other awards granted was $51.01 and $54.81 per share for the three months ended March 30, 2019 and March 31, 2018, respectively, and $54.04 and $44.49 per share for the nine months ended March 30, 2019 and March 31, 2018, respectively.

The following table summarizes the outstanding and expected to vest RSUs and other awards as of March 30, 2019 and related activity during the nine months ended March 30, 2019:

	Number of Shares		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value(1)
Balance at June 30, 2018	5,524,432
Restricted stock units and other awards granted	1,614,379
Restricted stock units and other awards released	(1,377,399	)
Restricted stock units and other awards cancelled	(458,762	)
Balance at March 30, 2019	5,302,650		2.7	$	287,456,657
Outstanding and expected to vest, March 30, 2019	4,439,502		2.7	$	240,665,404

(1) Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of March 30, 2019.

The Company withheld shares totaling $23.0 million in value as a result of employee withholding taxes based on the value of RSUs on vesting date for the nine months ended March 30, 2019. Total payments for employees’ tax obligations to taxing authorities are reflected as financing activities within the Condensed Consolidated Statements of Cash Flows.

As of March 30, 2019, there was $162.6 million of unrecognized compensation expense related to 5.3 million unvested RSUs and other awards, which is expected to be recognized over a weighted average period of approximately 2.7 years.

Market Stock Units (MSUs)

The Company grants MSUs to senior members of management in lieu of granting stock options. For MSUs granted prior to September 2017, the performance metrics of this program are based on relative performance of the Company’s stock price as compared to the Semiconductor Exchange Traded Fund index SPDR S&P (the “XSD”). For MSUs granted in September 2017 and after, the performance metrics for this program are based on the total shareholder return ("TSR") of the Company relative to the TSR of the other companies included in the XSD. The fair value of MSUs is estimated using a Monte Carlo simulation model on the date of grant. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis. Compensation expense is recognized based on the initial valuation and is not subsequently adjusted as a result of the Company’s performance relative to that of the XSD or the TSR of the companies included in the XSD, as applicable. Vesting for MSUs is contingent upon both service and market conditions and has a four-year vesting cliff period. MSUs granted after August 2017 vest based upon annual performance and are subject to continued service through the end of the four-year period, but will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements.

The weighted-average fair value of MSUs granted was $75.48 and $51.03 per share for the nine months ended March 30, 2019 and March 31, 2018, respectively.

The following table summarizes the number of MSUs outstanding and expected to vest as of March 30, 2019 and their activity during the nine months ended March 30, 2019:

	Number of Shares		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value(1)
Balance at June 30, 2018	1,079,064
Market stock units granted	247,804
Market stock units released	(13,594	)
Market stock units cancelled	(264,742	)
Balance at March 30, 2019	1,048,532		2.7	$	56,840,920
Outstanding and expected to vest, March 30, 2019	976,524		2.7	$	52,937,345

(1) Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of March 30, 2019.

As of March 30, 2019, there was $31.3 million of unrecognized compensation expense related to 1.0 million unvested MSUs, which is expected to be recognized over a weighted average period of approximately 2.7 years.

Employee Stock Purchase Plan

Employees are granted rights to acquire common stock under the 2008 ESPP.

The fair value of 2008 ESPP rights granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model using the following assumptions for the offering periods outstanding:

	Three Months Ended		Nine Months Ended
	March 30, 2019	March 31, 2018	March 30, 2019	March 31, 2018
Expected holding period (in years)	0.5 years	0.5 years	0.5 years	0.5 years
Risk-free interest rate	2.4% - 2.6%	1.1% - 1.5%	1.6% - 2.6%	0.8% - 1.5%
Expected stock price volatility	27.5 % - 28.9%	20.5% - 20.7%	19.6% - 32.7 %	19.1% - 24.7%
Dividend yield	2.8% - 3.1%	3.0% - 3.1%	2.8% - 3.1%	3.0% - 3.4%

As of March 30, 2019, there was $5.3 million of unrecognized compensation expense related to the 2008 ESPP.

XML

Earnings Per Share

9 Months Ended

Mar. 30, 2019

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

EARNINGS PER SHARE

Basic earnings per share are computed using the weighted average number of shares of common stock outstanding during the period. For purposes of computing basic earnings per share, the weighted average number of outstanding shares of common stock excludes unvested RSUs and other awards as well as MSUs. Diluted earnings per share incorporates the incremental shares issuable upon the assumed exercise of stock options, assumed release of unvested RSUs and other awards as well as MSUs, and assumed issuance of common stock under the 2008 ESPP using the treasury stock method.

The following table sets forth the computation of basic and diluted earnings per share:

	Three Months Ended				Nine Months Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
	(in thousands, except per share data)
Numerator for basic earnings per share and diluted earnings per share
Net income	$	130,613	$	193,627	$	459,928	$	273,146
Denominator for basic earnings per share	273,221		280,850		275,831		281,525
Effect of dilutive securities:
Stock options, ESPP, RSUs, and MSUs	3,389		5,031		3,849		4,696
Denominator for diluted earnings per share	276,610		285,881		279,680		286,221
Earnings per share
Basic	$	0.48	$	0.69	$	1.67	$	0.97
Diluted	$	0.47	$	0.68	$	1.64	$	0.95

For the three months ended March 30, 2019 and March 31, 2018, and the nine months ended March 30, 2019 and March 31, 2018, no stock awards were determined to be anti-dilutive. Therefore, none were excluded from the calculation of diluted earnings per share.

XML

Segment Information

9 Months Ended

Mar. 30, 2019

Segment Reporting [Abstract]

Segment Information [Text Block]

SEGMENT INFORMATION

The Company designs, develops, manufactures and markets a broad range of linear and mixed signal integrated circuits. All of the Company's products are designed through a centralized R&D function, manufactured using centralized manufacturing (internal and external), and sold through a centralized sales force and shared wholesale distributors.

The Company currently has one operating segment and reportable segment. In accordance with ASC No. 280, Segment Reporting (“ASC 280”), the Company considers operating segments to be components of the Company’s business for which separate financial information is available that is evaluated regularly by the Company’s Chief Operating Decision Maker in deciding how to allocate resources and in assessing performance. The Chief Operating Decision Maker for the Company was assessed and determined to be the CEO. The CEO reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, the Company has determined that it has a single operating and reportable segment.

Enterprise-wide information is provided in accordance with ASC 280. Geographical revenue information is based on customers’ ship-to location. Long-lived assets consist of property, plant and equipment. Property, plant and equipment information is based on the physical location of the assets at the end of each fiscal year.

Net revenues from unaffiliated customers by geographic region were as follows:

	Three Months Ended				Nine Months Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
	(in thousands)
United States	$	63,970	$	75,760	$	200,944	$	223,021
China	183,753		219,160		611,768		662,114
Rest of Asia	176,396		222,207		583,616		586,109
Europe	104,124		114,254		316,155		329,939
Rest of World	14,140		17,218		45,301		45,730
	$	542,383	$	648,599	$	1,757,784	$	1,846,913

Net long-lived assets by geographic region were as follows:

	March 30, 2019		June 30, 2018
	(in thousands)
United States	$	359,743	$	361,432
Philippines	110,214		120,657
Rest of World	101,998		97,275
	$	571,955	$	579,364

XML

Comprehensive Income Loss

9 Months Ended

Mar. 30, 2019

Statement of Comprehensive Income [Abstract]

Comprehensive Income [Text Block]

COMPREHENSIVE INCOME (LOSS)

The changes in accumulated other comprehensive income (loss) by component and related tax effects in the nine months ended March 30, 2019 and March 31, 2018 were as follows:

(in thousands)	Unrealized Gains and (Losses) on Intercompany Receivables			Unrealized Gains and (Losses) on Post-Retirement Benefits			Cumulative Translation Adjustment			Unrealized Gains and (Losses) on Cash Flow Hedges			Unrealized Gains and (Losses) on Available-For-Sale Securities			Total
June 30, 2018	$	(6,280	)	$	(2,516	)	$	(1,136	)	$	(1,383	)	$	(3,670	)	$	(14,985	)
Other comprehensive income (loss) before reclassifications	—			—			—			(783		)	3,247			2,464
Amounts reclassified out of accumulated other comprehensive loss (income)	—			292			—			2,191			—			2,483
Tax effects	—			(60		)				(241		)	(131		)	(432		)
Other comprehensive income, net	—			232			—			1,167			3,116			4,515
March 30, 2019	$	(6,280	)	$	(2,284	)	$	(1,136	)	$	(216	)	$	(554	)	$	(10,470	)

(in thousands)	Unrealized Gains and (Losses) on Intercompany Receivables			Unrealized Gains and (Losses) on Post-Retirement Benefits			Cumulative Translation Adjustment			Unrealized Gains and (Losses) on Cash Flow Hedges			Unrealized Gains and (Losses) on Available-For-Sale Securities			Total
June 24, 2017	$	(6,280	)	$	(1,258	)	$	(1,136	)	$	18		$	(1,234	)	$	(9,890	)
Other comprehensive income (loss) before reclassifications	—			—			—			2,012			(3,707		)	(1,695		)
Amounts reclassified out of accumulated other comprehensive loss (income)	—			154			—			(1,834		)	—			(1,680		)
Tax effects	—			(168		)	—			(45		)	274			61
Other comprehensive income (loss), net	—			(14		)	—			133			(3,433		)	(3,314		)
March 31, 2018	$	(6,280	)	$	(1,272	)	$	(1,136	)	$	151		$	(4,667	)	$	(13,204	)

XML

Income Taxes

9 Months Ended

Mar. 30, 2019

Income Tax Disclosure [Abstract]

Income Taxes [Text Block]

INCOME TAXES

In the three and nine months ended March 30, 2019, the Company recorded an income tax provision of $29.8 million and $116.8 million, respectively, compared to $28.7 million and $328.0 million for the three and nine months ended March 31, 2018, respectively. The Company’s effective tax rate for the three and nine months ended March 30, 2019 was 18.6% and 20.3%, respectively, compared to the 12.9% and 54.6% for the three and nine months ended March 31, 2018, respectively.

On December 22, 2017 legislation, commonly referred to as the Tax Cuts and Jobs Act (the “Act”), was enacted. The Act included a one-time tax on accumulated unremitted earnings of our foreign subsidiaries (“Transition Tax”). SEC Staff Accounting Bulletin No. 118 allowed the use of provisional amounts (reasonable estimates) if accounting for the income tax effects of the Act was not completed. Provisional amounts must be adjusted within a one-year measurement period from the enactment date of the Act. In the second quarter of fiscal year 2018, the Company recorded a discrete $236.9 million provisional Transition Tax charge. During the measurement period, the Company gathered information and analyzed available guidance to more precisely compute the amount of the Transition Tax. In the second quarter of fiscal year 2019 the Company completed this work and recorded a discrete $22.1 million measurement period adjustment for the Transition Tax, which increased the Company’s effective tax rate for the nine months ended March 30, 2019 by 3.8%. As of the end of the second quarter of fiscal year 2019, the accounting for income tax effects of the Act has been completed.

The Act reduced the federal statutory tax rate from 35% to 21%, effective January 1, 2018, which resulted in a fiscal year 2018 federal statutory tax rate of 28.1% for the Company (average of a 35% rate for the first half of fiscal year 2018 and a 21% rate for the second half of fiscal year 2018). The Company’s federal statutory tax rate for fiscal year 2019 is 21%. In the second quarter of fiscal year 2018, the Company recorded a $13.7 million discrete charge to remeasure deferred tax assets and liabilities as of the enactment date of the Act to reflect the federal statutory tax rate reductions.

The Act included Global Intangible Low-Taxed Income (“GILTI”) provisions, which first impact the Company in fiscal year 2019. The GILTI provisions effectively subject income earned by the Company’s foreign subsidiaries to current U.S. tax at a rate of 10.5%, less foreign tax credits. The Company has elected to treat tax generated by the GILTI provisions as a period expense.

The Company’s federal statutory tax rate for fiscal year 2019 is 21%. The Company’s effective tax rate for the three months ended March 30, 2019 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by tax generated by the GILTI provisions, a $4.1 million discrete charge for differences between the Company's fiscal year 2018 tax returns and the tax provision originally recorded, and $5.7 million of discrete interest accruals for unrecognized tax benefits.

The Company’s effective tax rate for the nine months ended March 30, 2019 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by $21.0 million of discrete charges for the Transition Tax, tax generated by the GILTI provisions, $15.1 million of discrete interest accruals for unrecognized tax benefits, and $4.8 million of discrete charges for differences between the Company's fiscal year 2018 tax returns and the tax provision originally recorded.

The Company’s federal statutory tax rate for fiscal year 2018 was 28.1%. The Company’s effective tax rate for the three months ended March 31, 2018, was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, and $4.6 million of discrete excess tax benefits generated by the settlement of share-based awards, partially offset by $5.1 million of discrete interest accruals for unrecognized tax benefits.

The Company’s effective tax rate for the nine months ended March 31, 2018 was higher than the statutory rate primarily due to a $236.9 million discrete provisional charge for the Transition Tax, a $13.7 million discrete charge to remeasure deferred taxes as of the enactment date of the Act, and $13.1 million of discrete interest accruals for unrecognized tax benefits, partially offset by earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates and $8.3 million of discrete excess tax benefits generated by the settlement of share-based awards.

The Company engages in continuous discussions and negotiations with tax authorities regarding tax matters in various jurisdictions. It is reasonably possible that gross unrecognized tax benefits, including accrued interest and penalties, could decrease up to $448 million within the next twelve months, primarily due to the completion of federal tax audits, including any administrative appeals. The $448 million primarily relates to matters involving federal taxation of cross-border transactions.

The Company’s federal corporate income tax returns are audited on a recurring basis by the Internal Revenue Service (“IRS”). The IRS concluded its field examination of the Company’s federal corporate income tax returns for fiscal years 2009 through 2011 and issued an IRS Revenue Agent's Report in July 2016 that included proposed adjustments for transfer pricing issues related to cost sharing and buy-in license payments for the use of intangible property by one of the Company’s international subsidiaries. The Company disagreed with the proposed transfer pricing adjustments and related penalties, and in September 2016, the Company filed a protest to challenge the proposed adjustments and request a conference with the Appeals Office of the IRS. In May 2018, a preliminary understanding was reached with the IRS regarding the contested issues for the audit and post-audit years, which the Company expects may be finalized in fiscal year 2019 with the execution of a closing agreement. In June 2018, the Company made advance payments for audit and post-audit years tax of $140.7 million and interest of $37.4 million. These payments will reduce the accrual of interest on audit and post-audit years tax deficiencies that would be owed if the preliminary understanding is finalized. The Company’s reserves for unrecognized tax benefits are sufficient to cover the audit and post-audit years tax deficiencies that would be owed as a result of the preliminary understanding. In fiscal year 2017, the IRS commenced an audit of the Company’s federal corporate income tax returns for fiscal years 2012 through 2014, which is ongoing. In the first quarter of fiscal year 2019, the Company was notified that the IRS will commence an audit of the Company's federal corporate income tax returns for fiscal years 2015 through 2016.

XML

Commitments and Contingencies

9 Months Ended

Mar. 30, 2019

Product Warranties Disclosures [Abstract]

Commitments and Contingencies [Text Block]

COMMITMENTS AND CONTINGENCIES

Legal Proceedings

The Company is party or subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, including proceedings and claims that relate to intellectual property matters. While the outcome of these matters cannot be predicted with certainty, the Company does not believe that the outcome of any of these matters, individually or in the aggregate, will result in losses that are materially in excess of amounts already recognized or reserved, if any.

Indemnification

The Company indemnifies certain customers, distributors, suppliers and subcontractors for attorney fees, damages and costs awarded against such parties in certain circumstances in which the Company's products are alleged to infringe third party intellectual property rights, including patents, registered trademarks or copyrights. The terms of the Company's indemnification obligations are generally perpetual from the effective date of the agreement. In certain cases, there are limits on and exceptions to the Company's potential liability for indemnification relating to intellectual property infringement claims.

Pursuant to the Company's charter documents and separate written indemnification agreements, the Company has certain indemnification obligations to its current officers, employees and directors, as well as certain former officers and directors.

XML

Common Stock Repurchases

9 Months Ended

Mar. 30, 2019

Common Stock Repurchases [Abstract]

Common Stock Repurchases [Text Block]

COMMON STOCK REPURCHASES

On July 20, 2017, the Board of Directors of the Company authorized the repurchase of up to $1 billion of the Company's common stock. The stock repurchase authorization did not have an expiration date and the pace of repurchase activity depended on factors such as current stock price, levels of cash generation from operations, cash requirements, and other factors. All prior repurchase authorizations by the Company’s Board of Directors for the repurchase of common stock were cancelled and superseded by this repurchase authorization.

On October 30, 2018, the Board of Directors of the Company authorized the repurchase of up to $1.5 billion of the Company’s common stock. The stock repurchase authorization does not have an expiration date and the pace of repurchase activity will depend on factors such as current stock price, levels of cash generation from operations, cash requirements, and other factors. All prior repurchase authorizations by the Company’s Board of Directors for the repurchase of common stock were cancelled and superseded by this repurchase authorization.

During the nine months ended March 30, 2019, the Company repurchased approximately 8.0 million shares of its common stock for $437.0 million. As of March 30, 2019, the Company had remaining authorization of $1.2 billion for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company’s common stock and general market and business conditions.

XML

Acquisitions (Notes)

9 Months Ended

Mar. 30, 2019

Business Combinations [Abstract]

Business Combination Disclosure [Text Block]

ACQUISITION

On January 26, 2018, the Company acquired a privately-held corporation specializing in the development of high-performance USB and video extension technology. Total cash consideration paid in connection with this acquisition was $57.8 million, net of cash acquired. The Company also agreed to pay up to an additional $16.0 million if the acquired business achieves certain financial milestones for the annual period ended August 31, 2018 and annual period ending August 31, 2019. Out of the $16.0 million, $8.0 million was paid during the nine months ended March 30, 2019. The acquired assets included $26.0 million of developed technology and $10.5 million of other intangible assets. The Company also recorded $41.9 million of goodwill in connection with this acquisition. The goodwill is not deductible for tax purposes.

XML

Goodwill and Intangible Assets

9 Months Ended

Mar. 30, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets [Text Block]

GOODWILL AND INTANGIBLE ASSETS

Goodwill

The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable.

There were no changes to goodwill for the nine months ended March 30, 2019.

No indicators or instances of impairment were identified in the nine months and fiscal year ended March 30, 2019 and June 30, 2018, respectively.

Intangible assets consisted of the following:

	March 30, 2019						June 30, 2018
	Original Cost		Accumulated Amortization		Net		Original Cost		Accumulated Amortization		Net
	(in thousands)
Intellectual property	$	488,846	$	443,020	$	45,826	$	485,465	$	423,869	$	61,596
Customer relationships	116,505		105,229		11,276		116,294		103,217		13,077
Trade name	9,974		8,830		1,144		9,340		8,588		752
Patents	2,500		2,500		—		2,500		2,469		31
Total amortizable purchased intangible assets	617,825		559,579		58,246		613,599		538,143		75,456
In-process research & development (IPR&D)	2,790		—		2,790		2,790		—		2,790
Total purchased intangible assets	$	620,615	$	559,579	$	61,036	$	616,389	$	538,143	$	78,246

GOODWILL AND INTANGIBLE ASSETS

Goodwill

The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable.

There were no changes to goodwill for the nine months ended March 30, 2019.

No indicators or instances of impairment were identified in the nine months and fiscal year ended March 30, 2019 and June 30, 2018, respectively.

Intangible assets consisted of the following:

	March 30, 2019						June 30, 2018
	Original Cost		Accumulated Amortization		Net		Original Cost		Accumulated Amortization		Net
	(in thousands)
Intellectual property	$	488,846	$	443,020	$	45,826	$	485,465	$	423,869	$	61,596
Customer relationships	116,505		105,229		11,276		116,294		103,217		13,077
Trade name	9,974		8,830		1,144		9,340		8,588		752
Patents	2,500		2,500		—		2,500		2,469		31
Total amortizable purchased intangible assets	617,825		559,579		58,246		613,599		538,143		75,456
In-process research & development (IPR&D)	2,790		—		2,790		2,790		—		2,790
Total purchased intangible assets	$	620,615	$	559,579	$	61,036	$	616,389	$	538,143	$	78,246

The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income:

	Three Months Ended				Nine Months Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
	(in thousands)
Cost of goods sold	$	5,368	$	12,101	$	19,151	$	34,305
Intangible asset amortization	756		876		2,285		3,623
Total intangible asset amortization expenses	$	6,124	$	12,977	$	21,436	$	37,928

The following table represents the estimated future amortization expense of intangible assets as of March 30, 2019:

Fiscal Year	Amount
	(in thousands)
Remaining three months of 2019	$	4,793
2020	15,068
2021	13,368
2022	7,689
2023	7,205
Thereafter	10,123
Total intangible assets	$	58,246

XML

Recently Issued Accounting Pronouncements Cumulative effect of the changes to the condensed consolidated balance sheet from the adoption of Topic 606 (Tables)

9 Months Ended

Mar. 30, 2019

New Accounting Pronouncements or Change in Accounting Principle [Line Items]

Schedule of Prospective Adoption of New Accounting Pronouncements [Table Text Block]

The following table summarizes the impacts of adopting Topic 606 on the Company’s Condensed Consolidated Balance Sheet as of March 30, 2019 (in thousands):

	As Reported		If Reported Under Topic 605		Effect of Adoption of Topic 606
Accounts receivable, net	$	381,152	$	275,141	$	106,011
Price adjustment and other revenue reserves	106,011		—		106,011

Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]

The cumulative effect of the changes to the condensed consolidated balance sheet from the adoption of Topic 606 was as follows (in thousands):

	As of June 30, 2018		Effect of Adoption of Topic 606		As of July 1, 2018
Accounts receivable, net	$	280,072	$	141,652	$	421,724
Price adjustment and other revenue reserves	—		141,652		141,652

XML

Balance Sheet Components (Tables)

9 Months Ended

Mar. 30, 2019

Balance Sheet Related Disclosures [Abstract]

Schedule of Inventory, Current [Table Text Block]

Inventories consist of:

	March 30, 2019		June 30, 2018
Inventories:	(in thousands)
Raw materials	$	18,799	$	16,251
Work-in-process	172,020		173,859
Finished goods	82,013		92,280
	$	272,832	$	282,390

Property, Plant and Equipment [Table Text Block]

Property, plant and equipment, net consists of:

	March 30, 2019			June 30, 2018
Property, plant and equipment, net:	(in thousands)
Land	$	17,731		$	17,731
Buildings and building improvements	258,642			254,733
Machinery, equipment and software	1,358,892			1,309,487
	1,635,265			1,581,951
Less: accumulated depreciation	(1,063,310		)	(1,002,587		)
	$	571,955		$	579,364

Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]

Accrued salary and related expenses consist of:

	March 30, 2019		June 30, 2018
Accrued salary and related expenses:	(in thousands)
Accrued vacation	$	28,831	$	30,695
Accrued bonus	56,187		92,288
Accrued salaries	13,711		8,210
ESPP withholding	15,634		5,158
Accrued fringe benefits	8,075		4,752
Other	5,927		10,579
	$	128,365	$	151,682

XML

Fair Value Measurements (Tables)

9 Months Ended

Mar. 30, 2019

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

Assets and liabilities measured at fair value on a recurring basis were as follows:

	As of March 30, 2019								As of June 30, 2018
	Fair Value  Measurements Using						Total Balance		Fair Value  Measurements Using						Total Balance
	Level 1		Level 2		Level 3				Level 1		Level 2		Level 3
	(in thousands)
Assets
Cash and cash equivalents
Agency securities	$	—	$	—	$	—	$	—	$	—	$	13,946	$	—	$	13,946
Certificates of deposit	—		—		—		—		—		6,000		—		6,000
Commercial paper	—		—		—		—		—		45,063		—		45,063
Corporate debt securities	—		—		—		—		—		3,819		—		3,819
Money market funds	195,805		—		—		195,805		98,467		—		—		98,467
U.S. Treasury securities	—		—		—		—		—		30,988		—		30,988
Short term investments
Certificates of deposit	—		5,000		—		5,000		—		52,428		—		52,428
Commercial paper	—		2,999		—		2,999		—		64,354		—		64,354
Corporate debt securities	—		185,994		—		185,994		—		367,765		—		367,765
U.S. Treasury securities	—		49,871		—		49,871		—		598,368		—		598,368
Other current assets
Foreign currency forward contracts	—		230		—		230		—		235		—		235
Total assets	$	195,805	$	244,094	$	—	$	439,899	$	98,467	$	1,182,966	$	—	$	1,281,433
Liabilities
Accrued expenses
Foreign currency forward contracts	$	—	$	496	$	—	$	496	$	—	$	1,845	$	—	$	1,845
Contingent consideration	—		—		9,052		9,052		—		—		8,000		8,000
Other liabilities
Contingent consideration	—		—		—		—		—		—		8,000		8,000
Total Liabilities	$	—	$	496	$	9,052	$	9,548	$	—	$	1,845	$	16,000	$	17,845

XML

Financial Instruments (Tables)

9 Months Ended

Mar. 30, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments, Gain (Loss) [Table Text Block]

The following tables summarize the gains (losses) from hedging activities recognized in the Company's Condensed Consolidated Statements of Income:

	Three Months Ended							Nine Months Ended
	March 30, 2019							March 30, 2019
	Net Revenue		Cost of Goods Sold		Operating Expenses				Net Revenue		Cost of Goods Sold			Operating Expenses
	(in thousands)
Income and expenses line items in which the effects of cash flow hedges are recorded	$	542,383	$	201,552	$	183,691			$	1,757,784	$	613,669		$	570,588
Gain (loss) on cash flow hedges:
Foreign exchange contracts:
Gain (loss) reclassified from accumulated other comprehensive income into income	$	6	$	261	$	(79	)		$	50	$	(335	)	$	(1,906	)

	Three Months Ended							Nine Months Ended
	March 31, 2018							March 31, 2018
	Net Revenue			Cost of Goods Sold		Operating Expenses			Net Revenue			Cost of Goods Sold		Operating Expenses
	(in thousands)
Income and expenses line items in which the effects of cash flow hedges are recorded	$	648,599		$	224,653	$	199,108		$	1,846,913		$	639,460	$	596,401
Gain (loss) on cash flow hedges:
Foreign exchange contracts:
Gain (loss) reclassified from accumulated other comprehensive income into income	$	(11	)	$	165	$	356		$	(64	)	$	116	$	1,781

Available-for-sale investments [Table Text Block]

Fair values were as follows:

	March 30, 2019									June 30, 2018
	Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Estimated Fair Value		Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Estimated Fair Value
	(in thousands)
Available-for-sale investments
Certificates of deposit	$	5,000	$	—	$	—		$	5,000	$	52,429	$	—	$	(1	)	$	52,428
Commercial paper	2,999		—		—			2,999		64,354		—		—			64,354
Corporate debt securities	186,446		21		(473		)	185,994		369,734		39		(2,008		)	367,765
U.S. Treasury securities	49,973		—		(102		)	49,871		600,068		10		(1,710		)	598,368
Total available-for-sale investments	$	244,418	$	21	$	(575	)	$	243,864	$	1,086,585	$	49	$	(3,719	)	$	1,082,915

Schedule of long-term debt [Table Text Block]

The following table summarizes the Company’s outstanding debt obligations:

	March 30, 2019			June 30, 2018
	(in thousands)
3.45% fixed rate notes due June 2027	$	500,000		$	500,000
2.5% fixed rate notes due November 2018	—			500,000
3.375% fixed rate notes due March 2023	500,000			500,000
Total outstanding debt	1,000,000			1,500,000
Less: Current portion (included in "Current portion of debt")	—			(499,406		)
Less: Reduction for unamortized discount and debt issuance costs	(7,775		)	(9,447		)
Total long-term debt	$	992,225		$	991,147

Financial Instruments [Text Block]

FINANCIAL INSTRUMENTS

Short-term investments

Fair values were as follows:

	March 30, 2019									June 30, 2018
	Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Estimated Fair Value		Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Estimated Fair Value
	(in thousands)
Available-for-sale investments
Certificates of deposit	$	5,000	$	—	$	—		$	5,000	$	52,429	$	—	$	(1	)	$	52,428
Commercial paper	2,999		—		—			2,999		64,354		—		—			64,354
Corporate debt securities	186,446		21		(473		)	185,994		369,734		39		(2,008		)	367,765
U.S. Treasury securities	49,973		—		(102		)	49,871		600,068		10		(1,710		)	598,368
Total available-for-sale investments	$	244,418	$	21	$	(575	)	$	243,864	$	1,086,585	$	49	$	(3,719	)	$	1,082,915

In the three and nine months ended March 30, 2019 and June 30, 2018, the Company did not recognize any impairment charges on short-term investments. All available-for-sale investments have maturity dates between April 1, 2019 and March 12, 2021.

The Company invests in various financial instruments including U.S. Treasury securities, corporate debt securities, commercial paper, and certificates of deposit which include instruments issued or managed by industrial, financial, and utility institutions and U.S. Treasury securities which include U.S. government Treasury bills and Treasury notes.

Derivative instruments and hedging activities

The Company incurs expenditures denominated in non-U.S. currencies, primarily the Philippine Peso and the Thai Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and the European Euro, Indian Rupee, Japanese Yen, Taiwan New Dollar, South Korean Won, Chinese Yuan and Canadian Dollar, for sales offices and research and development activities undertaken outside of the U.S.

The Company has established a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effects of certain foreign currency exposures. The Company does not use these foreign currency forward contracts for trading purposes.

Derivatives designated as cash flow hedging instruments

The Company designates certain forward contracts as hedging instruments pursuant to Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging (“ASC 815”). As of March 30, 2019 and June 30, 2018, the notional amounts of the forward contracts the Company held to purchase international currencies were $44.4 million and $49.7 million, respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $0 and $1.2 million, respectively.

Derivatives not designated as hedging instruments

As of March 30, 2019 and June 30, 2018, the notional amounts of the forward contracts the Company held to purchase international currencies were $19.9 million and $21.1 million, respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $21.9 million and $21.3 million, respectively. The Company's foreign currency forward contract gains or losses included in the Condensed Consolidated Statements of Income were not material for the three and nine months ended March 30, 2019 and March 31, 2018.

Effect of hedge accounting on the Condensed Consolidated Statements of Income

The following tables summarize the gains (losses) from hedging activities recognized in the Company's Condensed Consolidated Statements of Income:

	Three Months Ended							Nine Months Ended
	March 30, 2019							March 30, 2019
	Net Revenue		Cost of Goods Sold		Operating Expenses				Net Revenue		Cost of Goods Sold			Operating Expenses
	(in thousands)
Income and expenses line items in which the effects of cash flow hedges are recorded	$	542,383	$	201,552	$	183,691			$	1,757,784	$	613,669		$	570,588
Gain (loss) on cash flow hedges:
Foreign exchange contracts:
Gain (loss) reclassified from accumulated other comprehensive income into income	$	6	$	261	$	(79	)		$	50	$	(335	)	$	(1,906	)

	Three Months Ended							Nine Months Ended
	March 31, 2018							March 31, 2018
	Net Revenue			Cost of Goods Sold		Operating Expenses			Net Revenue			Cost of Goods Sold		Operating Expenses
	(in thousands)
Income and expenses line items in which the effects of cash flow hedges are recorded	$	648,599		$	224,653	$	199,108		$	1,846,913		$	639,460	$	596,401
Gain (loss) on cash flow hedges:
Foreign exchange contracts:
Gain (loss) reclassified from accumulated other comprehensive income into income	$	(11	)	$	165	$	356		$	(64	)	$	116	$	1,781

Outstanding debt obligations

The following table summarizes the Company’s outstanding debt obligations:

	March 30, 2019			June 30, 2018
	(in thousands)
3.45% fixed rate notes due June 2027	$	500,000		$	500,000
2.5% fixed rate notes due November 2018	—			500,000
3.375% fixed rate notes due March 2023	500,000			500,000
Total outstanding debt	1,000,000			1,500,000
Less: Current portion (included in "Current portion of debt")	—			(499,406		)
Less: Reduction for unamortized discount and debt issuance costs	(7,775		)	(9,447		)
Total long-term debt	$	992,225		$	991,147

On June 15, 2017, the Company completed a public offering of $500 million aggregate principal amount of the Company's 3.45% senior unsecured and unsubordinated notes due in June 2027 (“2027 Notes”), with an effective interest rate of 3.5%. Interest on the 2027 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, commencing on December 15, 2017. The net proceeds of this offering were approximately $495.2 million, after issuing at a discount and deducting paid expenses.

On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% coupon senior unsecured and unsubordinated notes due in November 2018 (“2018 Notes”), with an effective interest rate of 2.6%. Interest on the 2018 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing on May 15, 2014. The net proceeds of this offering were approximately $494.5 million, after issuing at a discount and deducting paid expenses. In November of 2018, the Company repaid the entire $500 million in principal and any outstanding interest, related to these outstanding notes.

On March 18, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 3.375% senior unsecured and unsubordinated notes due in March 2023 (“2023 Notes”), with an effective interest rate of 3.5%. Interest on the 2023 Notes is payable semi-annually in arrears on March 15 and September 15 of each year. The net proceeds of this offering were approximately $490.0 million, after issuing at a discount and deducting paid expenses.

The debt indentures that govern the 2027 Notes and the 2023 Notes include covenants that limit the Company's ability to grant liens on its facilities and to enter into sale and leaseback transactions, which could limit the Company's ability to secure additional debt funding in the future. In circumstances involving a change of control of the Company followed by a downgrade of the rating of the 2027 Notes or the 2023 Notes, the Company would be required to make an offer to repurchase the affected notes at a purchase price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest.

The Company accounts for all the notes above based on their amortized cost. The discount and expenses are being amortized to Interest and other income (expense), net in the Condensed Consolidated Statements of Income over the life of the notes. The interest expense is recorded in Interest and other income (expense), net in the Condensed Consolidated Statements of Income. Amortized discount and expenses, as well as interest expense associated with the notes, were $8.9 million and $12.4 million during the three months ended March 30, 2019 and March 31, 2018, respectively. Amortized discount and expenses, as well as interest expense associated with the notes, were $32.5 million and $37.1 million during the nine months ended March 30, 2019 and March 31, 2018, respectively.

The estimated fair value of the Company’s outstanding debt obligations was approximately $985 million as of March 30, 2019. The estimated fair value of the debt is based primarily on observable market inputs and is a Level 2 measurement.

The Company recorded interest expense of $9.3 million and $12.4 million during the three months ended March 30, 2019, and March 31, 2018, respectively. The Company recorded interest expense of $33.9 million and $37.6 million during the nine months ended March 30, 2019 and March 31, 2018, respectively.

Other Financial Instruments

For the balance of the Company’s financial instruments, cash equivalents, accounts receivable, accounts payable and other accrued liabilities, the carrying amounts approximate fair value due to their short maturities.

XML

Stock-Based Compensation (Tables)

9 Months Ended

Mar. 30, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

The following tables show total stock-based compensation expense by type of award, and the resulting tax effect, included in the Condensed Consolidated Statements of Income for the three and nine months ended March 30, 2019 and March 31, 2018, respectively:

	Three Months Ended
	March 30, 2019								March 31, 2018
	Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total		Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total
	(in thousands)
Cost of goods sold	$	8	$	1,951	$	654	$	2,613	$	35	$	2,003	$	537	$	2,575
Research and development	5		9,399		1,658		11,062		13		8,725		1,339		10,077
Selling, general and administrative	64		8,184		897		9,145		51		7,218		684		7,953
Pre-tax stock-based compensation expense	$	77	$	19,534	$	3,209	$	22,820	$	99	$	17,946	$	2,560	$	20,605
Less: income tax effect							1,946								2,053
Net stock-based compensation expense							$	20,874							$	18,552

	Nine Months Ended
	March 30, 2019								March 31, 2018
	Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total		Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total
	(in thousands)
Cost of goods sold	$	28	$	5,597	$	1,656	$	7,281	$	196	$	5,783	$	1,482	$	7,461
Research and development	27		26,783		3,948		30,758		507		24,212		3,342		28,061
Selling, general and administrative	178		24,600		2,156		26,934		636		21,004		1,770		23,410
Pre-tax stock-based compensation expense	$	233	$	56,980	$	7,760	$	64,973	$	1,339	$	50,999	$	6,594	$	58,932
Less: income tax effect							6,214								6,830
Net stock-based compensation expense							$	58,759							$	52,102

Share-based Compensation Arrangements by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]

The following table summarizes outstanding, exercisable and vested and expected to vest stock options as of March 30, 2019 and related activity for the nine months ended March 30, 2019:

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value(1)
Balance at June 30, 2018	1,688,253		$	27.72
Options Granted	—		—
Options Exercised	(699,416	)	27.13
Options Cancelled	(3,439	)	28.08
Balance at March 30, 2019	985,398		$	28.14	1.3	$	25,692,173
Exercisable, March 30, 2019	985,398		$	28.14	1.3	$	25,692,173
Vested and expected to vest, March 30, 2019	985,398		$	28.14	1.3	$	25,692,173

(1) Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of March 30, 2019.

Share-based Compensation Arrangements by Share-based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block]

The following table summarizes the outstanding and expected to vest RSUs and other awards as of March 30, 2019 and related activity during the nine months ended March 30, 2019:

	Number of Shares		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value(1)
Balance at June 30, 2018	5,524,432
Restricted stock units and other awards granted	1,614,379
Restricted stock units and other awards released	(1,377,399	)
Restricted stock units and other awards cancelled	(458,762	)
Balance at March 30, 2019	5,302,650		2.7	$	287,456,657
Outstanding and expected to vest, March 30, 2019	4,439,502		2.7	$	240,665,404

(1) Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of March 30, 2019.

Share-based Compensation Arrangements by Share-based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block]

The following table summarizes the number of MSUs outstanding and expected to vest as of March 30, 2019 and their activity during the nine months ended March 30, 2019:

	Number of Shares		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value(1)
Balance at June 30, 2018	1,079,064
Market stock units granted	247,804
Market stock units released	(13,594	)
Market stock units cancelled	(264,742	)
Balance at March 30, 2019	1,048,532		2.7	$	56,840,920
Outstanding and expected to vest, March 30, 2019	976,524		2.7	$	52,937,345

(1) Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of March 30, 2019.

Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]

The fair value of 2008 ESPP rights granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model using the following assumptions for the offering periods outstanding:

	Three Months Ended		Nine Months Ended
	March 30, 2019	March 31, 2018	March 30, 2019	March 31, 2018
Expected holding period (in years)	0.5 years	0.5 years	0.5 years	0.5 years
Risk-free interest rate	2.4% - 2.6%	1.1% - 1.5%	1.6% - 2.6%	0.8% - 1.5%
Expected stock price volatility	27.5 % - 28.9%	20.5% - 20.7%	19.6% - 32.7 %	19.1% - 24.7%
Dividend yield	2.8% - 3.1%	3.0% - 3.1%	2.8% - 3.1%	3.0% - 3.4%

XML

Earnings Per Share (Tables)

9 Months Ended

Mar. 30, 2019

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

The following table sets forth the computation of basic and diluted earnings per share:

	Three Months Ended				Nine Months Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
	(in thousands, except per share data)
Numerator for basic earnings per share and diluted earnings per share
Net income	$	130,613	$	193,627	$	459,928	$	273,146
Denominator for basic earnings per share	273,221		280,850		275,831		281,525
Effect of dilutive securities:
Stock options, ESPP, RSUs, and MSUs	3,389		5,031		3,849		4,696
Denominator for diluted earnings per share	276,610		285,881		279,680		286,221
Earnings per share
Basic	$	0.48	$	0.69	$	1.67	$	0.97
Diluted	$	0.47	$	0.68	$	1.64	$	0.95

XML

Segment Information (Tables)

9 Months Ended

Mar. 30, 2019

Segment Reporting [Abstract]

Schedule of Revenue from External Customers by Geographical Areas [Table Text Block]

Net revenues from unaffiliated customers by geographic region were as follows:

	Three Months Ended				Nine Months Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
	(in thousands)
United States	$	63,970	$	75,760	$	200,944	$	223,021
China	183,753		219,160		611,768		662,114
Rest of Asia	176,396		222,207		583,616		586,109
Europe	104,124		114,254		316,155		329,939
Rest of World	14,140		17,218		45,301		45,730
	$	542,383	$	648,599	$	1,757,784	$	1,846,913

Schedule of Long Lived Assets by Geographical Areas [Table Text Block]

Net long-lived assets by geographic region were as follows:

	March 30, 2019		June 30, 2018
	(in thousands)
United States	$	359,743	$	361,432
Philippines	110,214		120,657
Rest of World	101,998		97,275
	$	571,955	$	579,364

XML

Comprehensive Income Loss (Tables)

9 Months Ended

Mar. 30, 2019

Statement of Comprehensive Income [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

The changes in accumulated other comprehensive income (loss) by component and related tax effects in the nine months ended March 30, 2019 and March 31, 2018 were as follows:

(in thousands)	Unrealized Gains and (Losses) on Intercompany Receivables			Unrealized Gains and (Losses) on Post-Retirement Benefits			Cumulative Translation Adjustment			Unrealized Gains and (Losses) on Cash Flow Hedges			Unrealized Gains and (Losses) on Available-For-Sale Securities			Total
June 30, 2018	$	(6,280	)	$	(2,516	)	$	(1,136	)	$	(1,383	)	$	(3,670	)	$	(14,985	)
Other comprehensive income (loss) before reclassifications	—			—			—			(783		)	3,247			2,464
Amounts reclassified out of accumulated other comprehensive loss (income)	—			292			—			2,191			—			2,483
Tax effects	—			(60		)				(241		)	(131		)	(432		)
Other comprehensive income, net	—			232			—			1,167			3,116			4,515
March 30, 2019	$	(6,280	)	$	(2,284	)	$	(1,136	)	$	(216	)	$	(554	)	$	(10,470	)

(in thousands)	Unrealized Gains and (Losses) on Intercompany Receivables			Unrealized Gains and (Losses) on Post-Retirement Benefits			Cumulative Translation Adjustment			Unrealized Gains and (Losses) on Cash Flow Hedges			Unrealized Gains and (Losses) on Available-For-Sale Securities			Total
June 24, 2017	$	(6,280	)	$	(1,258	)	$	(1,136	)	$	18		$	(1,234	)	$	(9,890	)
Other comprehensive income (loss) before reclassifications	—			—			—			2,012			(3,707		)	(1,695		)
Amounts reclassified out of accumulated other comprehensive loss (income)	—			154			—			(1,834		)	—			(1,680		)
Tax effects	—			(168		)	—			(45		)	274			61
Other comprehensive income (loss), net	—			(14		)	—			133			(3,433		)	(3,314		)
March 31, 2018	$	(6,280	)	$	(1,272	)	$	(1,136	)	$	151		$	(4,667	)	$	(13,204	)

XML

Goodwill and Intangible Assets (Tables)

9 Months Ended

Mar. 30, 2019

Mar. 31, 2018

Goodwill [Line Items]

Goodwill and Intangible Assets Disclosure [Text Block]

GOODWILL AND INTANGIBLE ASSETS

Goodwill

The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable.

There were no changes to goodwill for the nine months ended March 30, 2019.

No indicators or instances of impairment were identified in the nine months and fiscal year ended March 30, 2019 and June 30, 2018, respectively.

Intangible assets consisted of the following:

	March 30, 2019						June 30, 2018
	Original Cost		Accumulated Amortization		Net		Original Cost		Accumulated Amortization		Net
	(in thousands)
Intellectual property	$	488,846	$	443,020	$	45,826	$	485,465	$	423,869	$	61,596
Customer relationships	116,505		105,229		11,276		116,294		103,217		13,077
Trade name	9,974		8,830		1,144		9,340		8,588		752
Patents	2,500		2,500		—		2,500		2,469		31
Total amortizable purchased intangible assets	617,825		559,579		58,246		613,599		538,143		75,456
In-process research & development (IPR&D)	2,790		—		2,790		2,790		—		2,790
Total purchased intangible assets	$	620,615	$	559,579	$	61,036	$	616,389	$	538,143	$	78,246

GOODWILL AND INTANGIBLE ASSETS

Goodwill

The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable.

There were no changes to goodwill for the nine months ended March 30, 2019.

No indicators or instances of impairment were identified in the nine months and fiscal year ended March 30, 2019 and June 30, 2018, respectively.

Intangible assets consisted of the following:

	March 30, 2019						June 30, 2018
	Original Cost		Accumulated Amortization		Net		Original Cost		Accumulated Amortization		Net
	(in thousands)
Intellectual property	$	488,846	$	443,020	$	45,826	$	485,465	$	423,869	$	61,596
Customer relationships	116,505		105,229		11,276		116,294		103,217		13,077
Trade name	9,974		8,830		1,144		9,340		8,588		752
Patents	2,500		2,500		—		2,500		2,469		31
Total amortizable purchased intangible assets	617,825		559,579		58,246		613,599		538,143		75,456
In-process research & development (IPR&D)	2,790		—		2,790		2,790		—		2,790
Total purchased intangible assets	$	620,615	$	559,579	$	61,036	$	616,389	$	538,143	$	78,246

The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income:

	Three Months Ended				Nine Months Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
	(in thousands)
Cost of goods sold	$	5,368	$	12,101	$	19,151	$	34,305
Intangible asset amortization	756		876		2,285		3,623
Total intangible asset amortization expenses	$	6,124	$	12,977	$	21,436	$	37,928

The following table represents the estimated future amortization expense of intangible assets as of March 30, 2019:

Fiscal Year	Amount
	(in thousands)
Remaining three months of 2019	$	4,793
2020	15,068
2021	13,368
2022	7,689
2023	7,205
Thereafter	10,123
Total intangible assets	$	58,246

Schedule of intangible assets [Table Text Block]

Intangible assets consisted of the following:

	March 30, 2019						June 30, 2018
	Original Cost		Accumulated Amortization		Net		Original Cost		Accumulated Amortization		Net
	(in thousands)
Intellectual property	$	488,846	$	443,020	$	45,826	$	485,465	$	423,869	$	61,596
Customer relationships	116,505		105,229		11,276		116,294		103,217		13,077
Trade name	9,974		8,830		1,144		9,340		8,588		752
Patents	2,500		2,500		—		2,500		2,469		31
Total amortizable purchased intangible assets	617,825		559,579		58,246		613,599		538,143		75,456
In-process research & development (IPR&D)	2,790		—		2,790		2,790		—		2,790
Total purchased intangible assets	$	620,615	$	559,579	$	61,036	$	616,389	$	538,143	$	78,246

Schedule of amortization expense allocation of intangible assets [Table Text Block]

The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income:

	Three Months Ended				Nine Months Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
	(in thousands)
Cost of goods sold	$	5,368	$	12,101	$	19,151	$	34,305
Intangible asset amortization	756		876		2,285		3,623
Total intangible asset amortization expenses	$	6,124	$	12,977	$	21,436	$	37,928

Estimated future amortization expense of intangible assets [Table Text Block]

The following table represents the estimated future amortization expense of intangible assets as of March 30, 2019:

Fiscal Year	Amount
	(in thousands)
Remaining three months of 2019	$	4,793
2020	15,068
2021	13,368
2022	7,689
2023	7,205
Thereafter	10,123
Total intangible assets	$	58,246

XML

Recently Issued Accounting Pronouncements (Details) - USD ($)

3 Months Ended

9 Months Ended

Mar. 31, 2018

Mar. 30, 2019

Mar. 31, 2018

Jul. 01, 2018

Jun. 30, 2018

New Accounting Pronouncement, Early Adoption [Line Items]

Accounts Receivable, Net, Current

$ 381,152,000

$ 280,072,000

Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]

The cumulative effect of the changes to the condensed consolidated balance sheet from the adoption of Topic 606 was as follows (in thousands):

	As of June 30, 2018		Effect of Adoption of Topic 606		As of July 1, 2018
Accounts receivable, net	$	280,072	$	141,652	$	421,724
Price adjustment and other revenue reserves	—		141,652		141,652

Discrete income tax benefit generated by the settlement of share-based awards

$ 8,300,000

Cash flow from operating activities operating activities

$ 638,373,000

$ 672,805,000

Accounts Receivable, Net

$ 421,724,000

280,072,000

Price adjustment and other revenue reserves

106,011,000

$ 0

Adjustments for New Accounting Pronouncement [Member]

New Accounting Pronouncement, Early Adoption [Line Items]

New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets

$ 141,652,000

Accounting Standards Update 2014-09 [Member]

New Accounting Pronouncement, Early Adoption [Line Items]

Accounts Receivable, Net, Current

$ 275,141,000

XML

Recently Issued Accounting Pronouncements Schedule of prospective adoption of new accounting pronouncements (Details) - USD ($)	3 Months Ended
	Mar. 30, 2019	Jul. 01, 2018
Item Effected [Line Items]
Income Tax Effects Allocated Directly to Equity, Prior Period Adjustment	$ 2,500,000
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	$ 106,011,000
Adjustments for New Accounting Pronouncement [Member]
Item Effected [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets		$ 141,652,000

XML

Balance Sheet Components (Details) - USD ($) $ in Thousands	Mar. 30, 2019	Jun. 30, 2018
Inventories:
Raw materials	$ 18,799	$ 16,251
Work-in-process	172,020	173,859
Finished goods	82,013	92,280
Inventory, net	272,832	282,390
Property, plant and equipment:
Land	17,731	17,731
Buildings and building improvements	258,642	254,733
Machinery and equipment	1,358,892	1,309,487
Property, plant and equipment, gross	1,635,265	1,581,951
Less: accumulated depreciation and amortization	(1,063,310)	(1,002,587)
Property, plant and equipment, net	571,955	579,364
Employee-related Liabilities, Current [Abstract]
Accrued Vacation	28,831	30,695
Accrued Bonuses	56,187	92,288
Accrued Salaries	13,711	8,210
Accrued Employee Stock Purchase Program Withholding	15,634	5,158
Accrued Employee Benefits	8,075	4,752
Other	5,927	10,579
Accrued salary and related expenses	$ 128,365	$ 151,682

XML

Fair Value Measurements (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018	Jun. 30, 2018	Jun. 24, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impairment of long-lived assets	$ 0	$ 0	$ 753	$ 892
Interest Expense, Debt	8,900	12,400	32,500	37,100
Cash and cash equivalents	1,654,563	1,629,593	1,654,563	1,629,593	$ 1,543,484	$ 2,246,121
Available-for-sale Securities					1,082,915
Business Combination, Contingent Consideration, Liability		$ 16,000		$ 16,000	8,000
Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets	439,899		439,899		1,281,433
Total Liabilities	9,548		9,548		17,845
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets	195,805		195,805		98,467
Total Liabilities	0		0		0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets	244,094		244,094		1,182,966
Total Liabilities	496		496		1,845
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets	0		0		0
Total Liabilities	9,052		9,052		16,000
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	195,805		195,805		98,467
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	195,805		195,805		98,467
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents					0
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents					0
Commercial paper | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		45,063
Available-for-sale Securities	2,999		2,999		64,354
Commercial paper | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		45,063
Available-for-sale Securities	2,999		2,999		64,354
Corporate debt securities | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		3,819
Available-for-sale Securities	185,994		185,994		367,765
Corporate debt securities | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		3,819
Available-for-sale Securities	185,994		185,994		367,765
US Treasury Securities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0		0		30,988
Available-for-sale Securities	49,871		49,871		598,368
US Treasury Securities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities					0
US Treasury Securities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		30,988
Available-for-sale Securities	49,871		49,871		598,368
US Treasury Securities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities					0
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts	230		230		235
Foreign currency forward contracts	496		496		1,845
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts					0
Foreign currency forward contracts	0		0		0
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts	230		230		235
Foreign currency forward contracts	496		496		1,845
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts					0
Foreign currency forward contracts	0		0		0
Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability	9,052		9,052		8,000
Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability	9,052		9,052
Certificates of deposit | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		6,000
Available-for-sale Securities	5,000		5,000		52,428
Certificates of deposit | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		6,000
Available-for-sale Securities	5,000		5,000		52,428
Agency Securities | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		13,946
Agency Securities | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		0
Agency Securities | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		13,946
Agency Securities | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		0
Other Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability	$ 0		$ 0		8,000
Other Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability					$ 8,000

XML

Financial Instruments, Short-term Investments (Details) - USD ($) $ in Thousands	Mar. 30, 2019	Jun. 30, 2018
Debt Securities, Available-for-sale [Abstract]
Estimated Fair Value		$ 1,082,915
Debt Securities, Available-for-sale, Amortized Cost	$ 244,418	1,086,585
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	21	49
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	575	3,719
Debt Securities, Available-for-sale	243,864
Certificates of deposit
Debt Securities, Available-for-sale [Abstract]
Debt Securities, Available-for-sale, Amortized Cost	5,000	52,429
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0	0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	0	1
Debt Securities, Available-for-sale	5,000	52,428
Commercial paper
Debt Securities, Available-for-sale [Abstract]
Debt Securities, Available-for-sale, Amortized Cost	2,999	64,354
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax		0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax		0
Debt Securities, Available-for-sale	2,999	64,354
Corporate debt securities
Debt Securities, Available-for-sale [Abstract]
Debt Securities, Available-for-sale, Amortized Cost	186,446	369,734
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	21	39
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	473	2,008
Debt Securities, Available-for-sale	185,994	367,765
U.S. Treasury securities
Debt Securities, Available-for-sale [Abstract]
Debt Securities, Available-for-sale, Amortized Cost	49,973	600,068
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0	10
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	102	1,710
Debt Securities, Available-for-sale	$ 49,871	$ 598,368

XML

Financial Instruments Financial Instruments, Securities Received as Consideration (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Jun. 30, 2018
Investment [Line Items]
Proceeds from sale of shares	$ 30,192	$ 100,004
Estimated Fair Value			$ 1,082,915
Not Designated as Hedging Instrument [Member] | Forward contracts held to purchase U.S. dollars [Member]
Investment [Line Items]
Derivative, Notional Amount	19,900		21,100
Not Designated as Hedging Instrument [Member] | Forward contracts held to sell U.S. dollars [Member]
Investment [Line Items]
Derivative, Notional Amount	21,900		21,300
Designated as Hedging Instrument [Member] | Forward contracts held to purchase U.S. dollars [Member] | Cash Flow Hedging [Member]
Investment [Line Items]
Derivative, Notional Amount	44,400		49,700
Designated as Hedging Instrument [Member] | Forward contracts held to sell U.S. dollars [Member] | Cash Flow Hedging [Member]
Investment [Line Items]
Derivative, Notional Amount	$ 0		$ 1,200

XML

Financial Instruments, Balance Sheet Location (Details) - USD ($) $ in Millions	Mar. 30, 2019	Jun. 30, 2018
Derivatives designated as hedging instruments [Member] | Cash Flow Hedging [Member] | Forward contracts held to purchase U.S. dollars [Member]
Derivatives, Fair Value [Line Items]
Notional amount of derivatives	$ 44.4	$ 49.7
Derivatives designated as hedging instruments [Member] | Cash Flow Hedging [Member] | Forward contracts held to sell U.S. dollars [Member]
Derivatives, Fair Value [Line Items]
Notional amount of derivatives	0.0	1.2
Derivatives not designated as hedging instruments [Member] | Forward contracts held to purchase U.S. dollars [Member]
Derivatives, Fair Value [Line Items]
Notional amount of derivatives	19.9	21.1
Derivatives not designated as hedging instruments [Member] | Forward contracts held to sell U.S. dollars [Member]
Derivatives, Fair Value [Line Items]
Notional amount of derivatives	$ 21.9	$ 21.3

XML

Financial Instruments, Long-term Debt (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018	Jun. 30, 2018	Jun. 24, 2017	Mar. 30, 2013
Debt Instrument [Line Items]
Debt, Long-term and Short-term, Combined Amount	$ 1,000,000		$ 1,000,000		$ 1,500,000
Short-term Debt	0		0		(499,406)
Less: Reduction for unamortized discount and debt issuance costs	(7,775)				(9,447)
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed						101.00%
Interest expense relating to the Notes	8,900	$ 12,400	32,500	$ 37,100
Estimated fair value of long-term debt	985,000		985,000
Interest Expense	9,300	12,400	33,900	37,600
Secured Long-term Debt, Noncurrent	992,225		992,225		991,147
Fixed Rate Note Due June 2027 at 3 Point 45 Percent [Member]
Debt Instrument [Line Items]
Long-term debt	500,000		500,000		500,000	$ 500,000
Fixed Rate Note Due November 2018 at 2 Point 50 Percent [Member]
Debt Instrument [Line Items]
Long-term debt	$ 0	$ 500,000	$ 0	$ 500,000	$ 500,000
Stated interest rate of the notes	2.50%		2.50%		2.50%
Fxed Rate Note Due March 2023 at 3 Point 375 Percent [Member]
Debt Instrument [Line Items]
Long-term debt	$ 500,000		$ 500,000		$ 500,000		$ 500,000
Effective interest rate of the Notes							3.50%
proceeds from issuance of long term debt 3							$ 490,000
FixedRateNoteDueJune2027at3Point450Percent[Member] [Member]
Debt Instrument [Line Items]
Stated interest rate of the notes	3.45%		3.45%		3.45%	3.45%
Fixed Rate Note Due June 2027 at 3 Point 50 Percent [Member] [Domain]
Debt Instrument [Line Items]
Effective interest rate of the Notes						3.50%
Fixed Rate Note Due June 2027 at 3 Point 50 Percent [Member] [Member]
Debt Instrument [Line Items]
Net Proceeds From Issuance of Long Term Debt 5						$ 495,200
Fixed Rate Note Due March 2023 at 3 Point 375 Percent [Member]
Debt Instrument [Line Items]
Stated interest rate of the notes	3.375%		3.375%		3.375%		3.375%

XML

Financial Instruments Gain (Loss) from Hedging Activities (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Derivative [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 542,383	$ 648,599	$ 1,757,784	$ 1,846,913
Cost of goods sold	201,552	224,653	613,669	639,460
Revenues	542,383	648,599	1,757,784	1,846,913
Operating Expenses	183,691	199,108	570,588	596,401
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			(2,483)	1,680
Accumulated Net Gain (Loss) from Cost of Good Solds Attributable to Parent [Member] [Member]
Derivative [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	261	165	(335)	116
Accumulated Net Gain (Loss) from Operating Expense Attributable to Parent [Member] [Member] [Member]
Derivative [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	(79)	356	(1,906)	1,781
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Derivative [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	$ 6	$ (11)	$ 50	$ (64)

XML

Stock-Based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	$ 22,820	$ 20,605	$ 64,973	$ 58,932
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	1,946	2,053	6,214	6,830
Net stock-based compensation expense	20,874	18,552	58,759	52,102
Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	2,613	2,575	7,281	7,461
Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	11,062	10,077	30,758	28,061
General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	9,145	7,953
Stock options [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	77	99	233	1,339
Stock options [Member] | Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	8	35	28	196
Stock options [Member] | Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	5	13	27	507
Stock options [Member] | General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	64	51
Restricted Stock Units (RSUs) [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	19,534	17,946
Restricted Stock Units (RSUs) [Member] | Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	1,951	2,003	5,597	5,783
Restricted Stock Units (RSUs) [Member] | Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	9,399	8,725	26,783	24,212
Restricted Stock Units (RSUs) [Member] | General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	8,184	7,218
ESP Plan [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	3,209	2,560	7,760	6,594
ESP Plan [Member] | Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	654	537	1,656	1,482
ESP Plan [Member] | Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	1,658	1,339	3,948	3,342
ESP Plan [Member] | General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	897	684
Market stock units [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	$ 3,000	$ 2,200	$ 8,300	$ 5,800

XML

Stock-Based Compensation, Stock Option Plans (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	9 Months Ended
	Mar. 30, 2019	Mar. 30, 2019	Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Unrecognized compensation costs related to unvested units	$ 162,600	$ 162,600
Weighted average period of recognition for unrecognized compensation costs (in years)		2 years 8 months	2 years 8 months
Stock options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options outstanding, beginning		1,688,253,000
Options Granted	0	0
Options Exercised		(699,416,000)
Options Cancelled		(3,439,000)
Options outstanding, ending	985,398,000	985,398,000
Options exercisable, number of shares	985,398,000	985,398,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options outstanding, weighted average exercise price, beginning (per share)		$ 27.72
Options granted, weighted average exercise price (per share)		0.00
Options exercised, weighted average exercise price (per share)		27,130
Options cancelled, weighted average exercise price (per share)		28,080
Options outstanding, weighted average exercise price, ending (per share)	$ 28,140	28,140
Options exercisable, weighted average exercise price (per share)	28,140	28,140
Options vested and expected to vest, weighted average exercise price (per share)	$ 28,140	$ 28,140
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Options outstanding, weighted average remaining contractual term (in years)		1 year 4 months
Options exercisable, weighted average remaining contractual term (in years)		1 year 4 months
Options vested and expected to vest, weighted average remaining contractual term (in years)		1 year 4 months
Options outstanding, aggregate intrinsic value	$ 25,692,173	$ 25,692,173
Options exercisable, aggregate intrinsic value	25,692,173	25,692,173
Options vested and expected to vest, aggregate intrinsic value	25,692,173	25,692,173
Unrecognized compensation costs related to unvested units	$ 0	$ 0

XML

Stock-Based Compensation, Restricted Stock Units (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Outstanding and expected to vest RSUs [Roll Forward]
Outstanding, beginning		5,300,000
Outstanding, ending	1,000,000		1,000,000
Unrecognized compensation costs related to unvested units	$ 162,600		$ 162,600
Weighted average period of recognition for unrecognized compensation costs (in years)			2 years 8 months	2 years 8 months
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value (per share)	$ 51.01	$ 54.81	$ 54.04	$ 44.49
Outstanding and expected to vest RSUs [Roll Forward]
Outstanding, beginning			5,524,432,000
Granted			1,614,379,000
Released			(1,377,399,000)
Cancelled			(458,762,000)
Outstanding, ending	5,302,650,000		5,302,650,000
Expected to vest, number of shares	4,439,502,000		4,439,502,000
Outstanding, weighted average remaining contractual term (in years)			2 years 8 months
Restricted stock units vested and expected to vest, weighted average remaining contractual term 1			2 years 8 months
Outstanding, aggregate intrinsic value	$ 287,456,657		$ 287,456,657
Restricted stock units expected to vest, aggregate intrinsic value	$ 240,665,404		240,665,404
Value of restricted stock unit shares withheld for withholding tax			$ 23,000

XML

Stock-Based Compensation Stock Based Compensation, Market Stock Units (Details) - USD ($)
$ / shares in Units, $ in Thousands

3 Months Ended

9 Months Ended

Mar. 30, 2019

Mar. 31, 2018

Mar. 30, 2019

Mar. 31, 2018

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangements by Share-based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block]

The following table summarizes the number of MSUs outstanding and expected to vest as of March 30, 2019 and their activity during the nine months ended March 30, 2019:

	Number of Shares		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value(1)
Balance at June 30, 2018	1,079,064
Market stock units granted	247,804
Market stock units released	(13,594	)
Market stock units cancelled	(264,742	)
Balance at March 30, 2019	1,048,532		2.7	$	56,840,920
Outstanding and expected to vest, March 30, 2019	976,524		2.7	$	52,937,345

(1) Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of March 30, 2019.

Allocated Share-based Compensation Expense

$ 22,820

$ 20,605

$ 64,973

$ 58,932

Outstanding and expected to vest MSUs [Roll Forward]

Outstanding, beginning

5,300,000

Outstanding, ending

1,000,000

1,000,000

Unrecognized compensation costs related to unvested units

$ 162,600

$ 162,600

Weighted average period of recognition for unrecognized compensation costs (in years)

2 years 8 months

2 years 8 months

Performance Shares [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Allocated Share-based Compensation Expense

$ 3,000

$ 2,200

$ 8,300

$ 5,800

Market Stock Units [Member]

Outstanding and expected to vest MSUs [Roll Forward]

Weighted average grant date fair value (per share)

$ 75.48

$ 51.03

Outstanding, beginning

1,079,064,000

Granted

247,804,000

Released

(13,594,000)

Cancelled

(264,742,000)

Outstanding, ending

1,048,532,000

1,048,532,000

Expected to vest, number of shares

976,524,000

976,524,000

Outstanding, weighted average remaining contractual term (in years)

2 years 8 months

Outstanding and expected to Vest, weighted average remaining contractual term 3

2 years 8 months

Outstanding, aggregate intrinsic value

$ 56,840,920

$ 56,840,920

Outstanding and expected to vest, aggregate intrinsic value

52,937,345

52,937,345

Unrecognized compensation costs related to unvested units

$ 31,300

$ 31,300

XML

Stock-Based Compensation, Employee Stock Purchase Plan (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018	Jun. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 22,820	$ 20,605	$ 64,973	$ 58,932
Risk-free interest rate	2.40%	1.10%	1.60%	0.80%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	2.80%	3.00%	2.80%	3.00%
Unrecognized compensation costs related to unvested units	$ 162,600		$ 162,600
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			2 years 8 months	2 years 8 months
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	1,946	$ 2,053	$ 6,214	$ 6,830
Allocated Share-based Compensation Expense, Net of Tax	$ 20,874	$ 18,552	$ 58,759	$ 52,102
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum	2.60%	1.50%	2.60%	1.50%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum	27.50%	20.50%	19.60%	19.10%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum	28.91%	20.70%	32.69%	24.70%
Share Based Compensation Arrangement By Share Based Payment Award, Fair Value Assumptions, Expected Dividend Rate, Maximum	3.05%	3.10%	3.14%	3.40%
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 3,000	$ 2,200	$ 8,300	$ 5,800
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	985,398,000		985,398,000		1,688,253,000
Allocated Share-based Compensation Expense	$ 77	99	$ 233	1,339
Unrecognized compensation costs related to unvested units	0		0
ESP Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 3,209	$ 2,560	$ 7,760	$ 6,594
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	6 months	6 months	6 months	6 months
Unrecognized compensation costs related to unvested units	$ 5,300		$ 5,300
Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	19,534	$ 17,946
Cost of Sales [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	2,613	2,575	7,281	$ 7,461
Cost of Sales [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	8	35	28	196
Cost of Sales [Member] | ESP Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	654	537	1,656	1,482
Cost of Sales [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	1,951	2,003	5,597	5,783
Research and Development Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	11,062	10,077	30,758	28,061
Research and Development Expense [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	5	13	27	507
Research and Development Expense [Member] | ESP Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	1,658	1,339	3,948	3,342
Research and Development Expense [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	9,399	8,725	$ 26,783	$ 24,212
General and Administrative Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	9,145	7,953
General and Administrative Expense [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	64	51
General and Administrative Expense [Member] | ESP Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	897	684
General and Administrative Expense [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 8,184	$ 7,218

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Numerator for basic earnings per share and diluted earnings per share
Net income	$ 130,613	$ 193,627	$ 459,928	$ 273,146
Denominator for basic earnings per share	273,221,000	280,850,000	275,831,000	281,525,000
Effect of dilutive securities
Stock options, ESPP and RSUs	3,389,000	5,031,000	3,849,000	4,696,000
Denominator for diluted earnings per share	276,610,000	285,881,000	279,680,000	286,221,000
Earnings per share, Basic (per share)	$ 0.48	$ 0.69	$ 1.67	$ 0.97
Earnings per share, Diluted (per share)	$ 0.47	$ 0.68	$ 1.64	$ 0.95
Antidilutive securities excluded from computation of earnings per share	0	0	0	0

XML

Segment Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019 USD ($) customers	Mar. 31, 2018 USD ($)	Mar. 30, 2019 USD ($)	Mar. 31, 2018 USD ($)	Jun. 30, 2018 USD ($)
Segment Reporting Information [Line Items]
Number of Reportable Segments | customers	1
Revenues	$ 542,383	$ 648,599	$ 1,757,784	$ 1,846,913
Long-lived assets	571,955		571,955		$ 579,364
United States [Member]
Segment Reporting Information [Line Items]
Revenues	63,970	75,760	200,944	223,021
Long-lived assets	359,743		359,743		361,432
China [Member]
Segment Reporting Information [Line Items]
Revenues	183,753	219,160	611,768	662,114
Rest of Asia [Member]
Segment Reporting Information [Line Items]
Revenues	176,396	222,207	583,616	586,109
Europe [Member]
Segment Reporting Information [Line Items]
Revenues	104,124	114,254	316,155	329,939
Philippines [Member]
Segment Reporting Information [Line Items]
Long-lived assets	110,214		110,214		120,657
Rest of World [Member]
Segment Reporting Information [Line Items]
Revenues	14,140	$ 17,218	45,301	$ 45,730
Long-lived assets	$ 101,998		$ 101,998		$ 97,275

XML

Comprehensive Income Loss Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax			$ (14,985)	$ (9,890)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			2,464	(1,695)
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			2,483	(1,680)
Other Comprehensive Income (Loss), Tax			(432)	61
Other comprehensive income (loss), net	$ 866	$ (1,412)	4,515	(3,314)
Accumulated Other Comprehensive Income (Loss), Net of Tax	(10,470)	(13,204)	(10,470)	(13,204)
Unrealized Holding Gains (Losses) on Intercompany Receivables [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax			(6,280)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			0	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			0	0
Other Comprehensive Income (Loss), Tax			0	0
Other comprehensive income (loss), net			0	0
Accumulated Other Comprehensive Income (Loss), Net of Tax	(6,280)	(6,280)	(6,280)	(6,280)
Accumulated Defined Benefit Plans Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax			(2,516)	(1,258)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			0	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			292	154
Other Comprehensive Income (Loss), Tax			(60)	(168)
Other comprehensive income (loss), net			232	(14)
Accumulated Other Comprehensive Income (Loss), Net of Tax	(2,284)	(1,272)	(2,284)	(1,272)
Accumulated Translation Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax			(1,136)	(1,136)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			0	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			0	0
Other Comprehensive Income (Loss), Tax				0
Other comprehensive income (loss), net			0	0
Accumulated Other Comprehensive Income (Loss), Net of Tax	(1,136)	(1,136)	(1,136)	(1,136)
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax			(1,383)	18
Other Comprehensive Income (Loss), before Reclassifications, before Tax			(783)	2,012
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			2,191	(1,834)
Other Comprehensive Income (Loss), Tax			(241)	(45)
Other comprehensive income (loss), net			1,167	133
Accumulated Other Comprehensive Income (Loss), Net of Tax	(216)	151	(216)	151
Unrealized Holding Gains (losses) on Available-for-sale Investments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax			(3,670)	(1,234)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			3,247	(3,707)
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			0	0
Other Comprehensive Income (Loss), Tax			(131)	274
Other comprehensive income (loss), net			3,116	(3,433)
Accumulated Other Comprehensive Income (Loss), Net of Tax	$ (554)	$ (4,667)	$ (554)	$ (4,667)

XML

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Mar. 30, 2019	Dec. 29, 2018	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018	Jun. 24, 2017
Effective Income Tax Rate Reconcilliation, Share-based Compensation, Excess Tax Benefit, Amount [Line Items]
Unrecognized Tax Benefits, Interest on Income Taxes Expense			$ 13,100
Effective Income Tax Rate Reconciliation, Share-based Compensation, Excess Tax Benefit, Amount			8,300
Unrecognized Tax Benefits, Period Increase (Decrease)				$ 448,000
Advance payments for audit and post-audit year tax					$ 140,700
Interest payment on advance payments for audit and post-audit year tax					37,400
Effective Income Tax Rate Reconciliation, Share-based Compensation, Excess Tax Benefit, Amount			4,600
Income tax provision (benefit)	$ 29,845		$ 28,677	$ 116,843	$ 328,038
Effective Income Tax Rate Reconciliation, Percent	18.60%		12.90%	20.30%	54.60%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%				0.00%	35.00%
Effective Income Tax Reconciliation, Deferred Tax Remeasurement			$ 13,700
Effective Income Tax Reconciliation, Transition Tax			236,900	$ 4,100
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount		$ 22,100
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent	3.80%
Effective Income Tax Reconciliation, Interest Accruals	$ 5,700		$ 5,100	15,100
Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount	$ 21,000			$ 4,800

XML

Commitments and Contingencies (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Mar. 31, 2018
Business Acquisition, Contingent Consideration [Line Items]
Business Combination, Contingent Consideration, Liability	$ 8,000	$ 16,000

XML

Common Stock Repurchases (Details) - USD ($) $ in Thousands, shares in Millions	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018	Oct. 30, 2018	Jul. 20, 2017
Equity, Class of Treasury Stock [Line Items]
Stock Repurchased During Period, Shares			8.0
Stock Repurchased During Period, Value			$ 437,000
Stock repurchase program, authorized amount					$ 2,000,000	$ 1,000,000
Value of common stock repurchased	$ 116,991	$ 127,700	437,047	$ 279,946
Stock repurchase program, remaining authorized amount	$ 1,217,100		$ 1,217,100

XML

Acquisitions (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018	Jun. 30, 2018
Business Acquisition [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired	$ 57,800	$ 2,949	$ 57,773
Business Combination, Contingent Consideration, Liability	16,000		16,000	$ 8,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	26,000		26,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	10,500		10,500
Goodwill	$ 41,889	$ 532,251	$ 41,889	$ 532,251

XML

Goodwill and Intangible Assets, Goodwill (Details) - USD ($) $ in Thousands	Mar. 30, 2019	Jun. 30, 2018	Mar. 31, 2018
Goodwill [Line Items]
Goodwill	$ 532,251	$ 532,251	$ 41,889

XML

Goodwill and Intangible Assets, Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018	Jun. 30, 2018
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	$ 617,825		$ 617,825		$ 613,599
Accumulated Amortization	559,579		559,579		538,143
Net	58,246		58,246		75,456
Intangible Assets, Gross	620,615		620,615		616,389
Total purchased intangible assets	61,036		61,036		78,246
Cost, Amortization	5,368	$ 12,101	19,151	$ 34,305
Intangible asset amortization	756	876	2,285	3,623
Intangible Asset Amortization Expense	6,124	$ 12,977	21,436	$ 37,928
Future amortization expense [Abstract]
Remaining three months of 2017	4,793		4,793
2019	15,068		15,068
2020	13,368		13,368
2021	7,689		7,689
2022	7,205		7,205
Thereafter	10,123		10,123
Net	58,246		58,246		75,456
Intellectual Property [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	488,846		488,846		485,465
Accumulated Amortization	443,020		443,020		423,869
Net	45,826		45,826		61,596
Future amortization expense [Abstract]
Net	45,826		45,826		61,596
Customer relationships [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	116,505		116,505		116,294
Accumulated Amortization	105,229		105,229		103,217
Net	11,276		11,276		13,077
Future amortization expense [Abstract]
Net	11,276		11,276		13,077
Tradename [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	9,974		9,974		9,340
Accumulated Amortization	8,830		8,830		8,588
Net	1,144		1,144		752
Future amortization expense [Abstract]
Net	1,144		1,144		752
Patents [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	2,500		2,500		2,500
Accumulated Amortization	2,500		2,500		2,469
Net	0		0		31
Future amortization expense [Abstract]
Net	0		0		31
In Process Research and Development [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
IPR&D	$ 2,790		$ 2,790		$ 2,790

XML

Impairment of Long-Lived Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Long Lived Assets Held-for-sale [Line Items]
Impairment of long-lived assets	$ 0	$ 0	$ 753	$ 892
Gain (Loss) on Disposition of Property Plant Equipment			$ (3,324)	$ (572)

XML

Restructuring Activities (Details) - $ / shares	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Restructuring Cost and Reserve [Line Items]
Earnings per share, Diluted (per share)	$ 0.47	$ 0.68	$ 1.64	$ 0.95

XML

Restructuring Activities Change in Estimate (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Change in Accounting Estimate [Line Items]
Operating Income (Loss)	$ 157,140	$ 224,838	$ 573,527	$ 611,052
Net income	$ 130,613	$ 193,627	$ 459,928	$ 273,146
Basic	$ 0.48	$ 0.69	$ 1.67	$ 0.97
Diluted	$ 0.47	$ 0.68	$ 1.64	$ 0.95

XML

Label	Element	Value
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	$ 7,715,000
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	26,384,000
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	5,143,000
Dividends	us-gaap_Dividends	0
Dividends	us-gaap_Dividends	1.14
Dividends	us-gaap_Dividends	0.46
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	2,202,694,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	1,950,991,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	1,662,747,000
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	(9,641,000)
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	(21,161,000)
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	(9,582,000)
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	14,975,000
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	us-gaap_ProfitLoss	193,627,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	us-gaap_ProfitLoss	273,146,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	us-gaap_ProfitLoss	130,613,000
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	117,883,000
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	320,766,000
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	125,566,000
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20,587,000
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	58,979,000
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	$ 22,850,000
Common Stock, Shares, Outstanding	us-gaap_CommonStockSharesOutstanding	279,979,000
Retained Earnings [Member]
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	$ (109,039,000)
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	(200,769,000)
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	(98,580,000)
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	0
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	0
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	0
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	2,212,301,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	1,963,912,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	1,672,938,000
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	us-gaap_ProfitLoss	193,627,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	us-gaap_ProfitLoss	273,146,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	us-gaap_ProfitLoss	130,613,000
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	117,883,000
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	320,766,000
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	125,566,000
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	0
AOCI Attributable to Parent [Member]
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	0
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	0
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	0
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	0
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	0
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	0
Other Comprehensive Income (Loss), Net of Tax	us-gaap_OtherComprehensiveIncomeLossNetOfTax	(1,412,000)
Other Comprehensive Income (Loss), Net of Tax	us-gaap_OtherComprehensiveIncomeLossNetOfTax	(3,314,000)
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	(9,890,000)
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	(13,204,000)
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	(13,204,000)
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	(10,470,000)
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	0
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	0
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	0
Additional Paid-in Capital [Member]
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	(18,659,000)
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	(79,174,000)
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	(18,411,000)
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	7,714,000
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	26,382,000
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	5,143,000
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	(9,642,000)
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	(21,162,000)
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	(9,582,000)
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	14,975,000
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	0
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	0
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20,587,000
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	58,979,000
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	22,850,000
Common Stock [Member]
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	(2,000)
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	(3,000)
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	$ 0
Treasury Stock, Shares, Acquired	us-gaap_TreasuryStockSharesAcquired	2,140,000
Treasury Stock, Shares, Acquired	us-gaap_TreasuryStockSharesAcquired	5,286,000
Treasury Stock, Shares, Acquired	us-gaap_TreasuryStockSharesAcquired	2,210,000
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	$ 1,000
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	2,000
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	0
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	283,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	283,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	283,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	279,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	279,000
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1,000
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1,000
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	$ 0
Stock Issued During Period, Shares, Employee Stock Purchase Plans	us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans	us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	416,000
Stock Issued During Period, Shares, Employee Stock Purchase Plans	us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	0
Stock Issued During Period, Value, Employee Stock Ownership Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	$ 0
Stock Issued During Period, Value, Employee Stock Ownership Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	0
Stock Issued During Period, Value, Employee Stock Ownership Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	0
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	0
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	0
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	$ 0
Stock Issued During Period, Shares, Other	us-gaap_StockIssuedDuringPeriodSharesOther	294,000
Stock Issued During Period, Shares, Other	us-gaap_StockIssuedDuringPeriodSharesOther	1,031,000
Stock Issued During Period, Shares, Other	us-gaap_StockIssuedDuringPeriodSharesOther	177,000
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	$ 0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	$ 0
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	387,000
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	906,000
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	402,000